BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
948790	CC(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1			459216	US10759813, Example 1-B	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459216&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969619	441290479					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948791	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)C(O)=O)C(O)=O			459217	US10759813, Example 2-C	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459217	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459217&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			57378207	441290480					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948792	O[C@@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)C(O)=O)C(O)=O			459218	US10759813, Example 2-D	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459218	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459218&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969512	441290481					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948793	COCCN(C)C(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1			459219	US10759813, Example 3-C::US10759813, Example 3-D	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459219	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459219&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969701	441290482					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948794	COCCN(C)C(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1			459219	US10759813, Example 3-C::US10759813, Example 3-D	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459219	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459219&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969701	441290482					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948795	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)C(=O)N1CCC1)C(O)=O			459221	US10759813, Example 4-B	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459221&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969513	441290483					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948796	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)C(=O)N1CCCC1)C(O)=O			459222	US10759813, Example 5-B	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459222&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969492	441290484					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948797	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cnc(O)nc1)C(O)=O	InChI=1S/C22H21N3O5/c26-19(21(28)29)11-18(25-20(27)17-12-23-22(30)24-13-17)10-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-9,12-13,18-19,26H,10-11H2,(H,25,27)(H,28,29)(H,23,24,30)/t18-,19-/m1/s1	DRYQHTRVEJKXFP-RTBURBONSA-N	459223	US10759813, Example 6-B	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459223&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969499	441290485					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948798	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(O)no1)C(O)=O	InChI=1S/C21H20N2O6/c24-17(21(27)28)11-16(22-20(26)18-12-19(25)23-29-18)10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9,12,16-17,24H,10-11H2,(H,22,26)(H,23,25)(H,27,28)/t16-,17-/m1/s1	BEFVZLDKNIOQGT-IAGOWNOFSA-N	459224	US10759813, Example 7-B	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459224	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459224&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969474	441290486					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948799	CC(C)(O)c1cc(n[nH]1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1			459225	US10759813, Example 8-B	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459225	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459225&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969766	441290487					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948800	NC(=O)[C@H](O)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cnc(O)nc1	InChI=1S/C22H22N4O4/c23-20(28)19(27)11-18(26-21(29)17-12-24-22(30)25-13-17)10-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-9,12-13,18-19,27H,10-11H2,(H2,23,28)(H,26,29)(H,24,25,30)/t18-,19-/m1/s1	RGPRMLDDHPKBMO-RTBURBONSA-N	459226	2-Hydroxypyrimidine-5-carboxylic acid ((1R,3R)-1-biphenyl-4-ylmethyl-3-carbamoyl-3-hydroxypropyl)amide::US10759813, Example 9	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459226	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459226&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			57377988	441290488							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948801	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C20H20N4O4/c25-18(20(27)28)11-16(22-19(26)17-12-21-24-23-17)10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9,12,16,18,25H,10-11H2,(H,22,26)(H,27,28)(H,21,23,24)/t16-,18-/m1/s1	VYRGHEAJKZARGY-SJLPKXTDSA-N	459227	US10759813, Example 10-2	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459227&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903406	441290489					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948802	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cn(O)nn1)C(O)=O	InChI=1S/C20H20N4O5/c25-18(20(27)28)11-16(21-19(26)17-12-24(29)23-22-17)10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9,12,16,18,25,29H,10-11H2,(H,21,26)(H,27,28)/t16-,18-/m1/s1	SNSCPUQOYIVJFN-SJLPKXTDSA-N	459228	US10759813, Example 10-3	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459228	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459228&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969608	441290490					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948803	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1nc[nH]n1)C(O)=O	InChI=1S/C20H20N4O4/c25-17(20(27)28)11-16(23-19(26)18-21-12-22-24-18)10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9,12,16-17,25H,10-11H2,(H,23,26)(H,27,28)(H,21,22,24)/t16?,17-/m1/s1	XMLFXHSKKSJXKL-ZYMOGRSISA-N	459229	US10759813, Example 10-6	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459229	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459229&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969833	441290491					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948804	Cc1nc(nn1-c1ccc(Cl)cc1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C27H25ClN4O4/c1-17-29-25(31-32(17)23-13-11-21(28)12-14-23)26(34)30-22(16-24(33)27(35)36)15-18-7-9-20(10-8-18)19-5-3-2-4-6-19/h2-14,22,24,33H,15-16H2,1H3,(H,30,34)(H,35,36)/t22?,24-/m1/s1	ZABCSERNZUTWKZ-SYIFMXBLSA-N	459231	US10759813, Example 10-7	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459231&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969738	441290493					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948805	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1n[nH]c(O)n1)C(O)=O	InChI=1S/C20H20N4O5/c25-16(19(27)28)11-15(21-18(26)17-22-20(29)24-23-17)10-12-6-8-14(9-7-12)13-4-2-1-3-5-13/h1-9,15-16,25H,10-11H2,(H,21,26)(H,27,28)(H2,22,23,24,29)/t15-,16-/m1/s1	VFBKECNYAGHZRV-HZPDHXFCSA-N	459232	US10759813, Example 10-9	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459232	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459232&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			136480949	441290494					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948806	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1nnc([nH]1)-c1ccccn1)C(O)=O	InChI=1S/C25H23N5O4/c31-21(25(33)34)15-19(14-16-9-11-18(12-10-16)17-6-2-1-3-7-17)27-24(32)23-28-22(29-30-23)20-8-4-5-13-26-20/h1-13,19,21,31H,14-15H2,(H,27,32)(H,33,34)(H,28,29,30)/t19?,21-/m1/s1	JIEDPABZXGGKCZ-VGAJERRHSA-N	459233	US10759813, Example 10-10	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459233	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459233&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969888	441290495					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948807	Cc1n[nH]c(n1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C21H22N4O4/c1-13-22-19(25-24-13)20(27)23-17(12-18(26)21(28)29)11-14-7-9-16(10-8-14)15-5-3-2-4-6-15/h2-10,17-18,26H,11-12H2,1H3,(H,23,27)(H,28,29)(H,22,24,25)/t17?,18-/m1/s1	LBFAEEUYUNFHMW-QRWMCTBCSA-N	459234	US10759813, Example 10-11	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459234&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969670	441290496					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948808	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1nc(Cl)n[nH]1)C(O)=O	InChI=1S/C20H19ClN4O4/c21-20-23-17(24-25-20)18(27)22-15(11-16(26)19(28)29)10-12-6-8-14(9-7-12)13-4-2-1-3-5-13/h1-9,15-16,26H,10-11H2,(H,22,27)(H,28,29)(H,23,24,25)/t15-,16-/m1/s1	VWAHQEHCOZNFNE-HZPDHXFCSA-N	459235	US10759813, Example 10-12	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459235&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969624	441290497					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948809	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1ccc2n(Cc3cccc(c3)C(O)=O)nnc2c1)C(O)=O	InChI=1S/C32H28N4O6/c37-29(32(41)42)18-26(16-20-9-11-23(12-10-20)22-6-2-1-3-7-22)33-30(38)24-13-14-28-27(17-24)34-35-36(28)19-21-5-4-8-25(15-21)31(39)40/h1-15,17,26,29,37H,16,18-19H2,(H,33,38)(H,39,40)(H,41,42)/t26-,29?/m1/s1	HIBJQRPXRZNWNE-QZWVJJBASA-N	459236	US10759813, Example 11-1	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459236	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459236&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969712	441290498					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948810	O[C@@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1ccc2n(Cc3ccc(cc3)C(O)=O)nnc2c1)C(O)=O	InChI=1S/C32H28N4O6/c37-29(32(41)42)18-26(16-20-6-10-23(11-7-20)22-4-2-1-3-5-22)33-30(38)25-14-15-28-27(17-25)34-35-36(28)19-21-8-12-24(13-9-21)31(39)40/h1-15,17,26,29,37H,16,18-19H2,(H,33,38)(H,39,40)(H,41,42)/t26-,29+/m1/s1	BJTOAVQEZQKHJQ-UHSQPCAPSA-N	459237	US10759813, Example 11-2	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459237&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969721	441290499					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948811	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1ccc2[nH]nnc2c1)C(O)=O	InChI=1S/C24H22N4O4/c29-22(24(31)32)14-19(25-23(30)18-10-11-20-21(13-18)27-28-26-20)12-15-6-8-17(9-7-15)16-4-2-1-3-5-16/h1-11,13,19,22,29H,12,14H2,(H,25,30)(H,31,32)(H,26,27,28)/t19?,22-/m1/s1	MQJDBDUFOAMADZ-AVKWCDSFSA-N	459238	US10759813, Example 11-3	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459238&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903408	441290500					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948812	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(F)c2[nH]nnc2c1)C(O)=O	InChI=1S/C24H21FN4O4/c25-19-11-17(12-20-22(19)28-29-27-20)23(31)26-18(13-21(30)24(32)33)10-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-9,11-12,18,21,30H,10,13H2,(H,26,31)(H,32,33)(H,27,28,29)/t18?,21-/m1/s1	FXHQYGPHSSSPQF-BDPMCISCSA-N	459239	US10759813, Example 11-4	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459239&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903409	441290501					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948813	Cc1cc(cc2[nH]nnc12)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C25H24N4O4/c1-15-11-19(13-21-23(15)28-29-27-21)24(31)26-20(14-22(30)25(32)33)12-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h2-11,13,20,22,30H,12,14H2,1H3,(H,26,31)(H,32,33)(H,27,28,29)/t20?,22-/m1/s1	JXIIUZFDXATKSV-LWMIZPGFSA-N	459240	US10759813, Example 11-6	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459240&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903410	441290502					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948814	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1ccc2[nH]nnc2c1Cl)C(O)=O	InChI=1S/C24H21ClN4O4/c25-21-18(10-11-19-22(21)28-29-27-19)23(31)26-17(13-20(30)24(32)33)12-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-11,17,20,30H,12-13H2,(H,26,31)(H,32,33)(H,27,28,29)/t17?,20-/m1/s1	QUDNOUJRQKRXHS-UUSAFJCLSA-N	459241	US10759813, Example 11-7	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459241&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903411	441290503					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948815	Cc1nc2ccc(cc2o1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C26H24N2O5/c1-16-27-22-12-11-20(14-24(22)33-16)25(30)28-21(15-23(29)26(31)32)13-17-7-9-19(10-8-17)18-5-3-2-4-6-18/h2-12,14,21,23,29H,13,15H2,1H3,(H,28,30)(H,31,32)/t21?,23-/m1/s1	ZKURWRBNNAVMHD-JFGZAKSSSA-N	459242	US10759813, Example 11-8	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459242&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969774	441290504					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948816	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cnc2[nH]cnc2c1)C(O)=O	InChI=1S/C24H22N4O4/c29-21(24(31)32)12-19(28-23(30)18-11-20-22(25-13-18)27-14-26-20)10-15-6-8-17(9-7-15)16-4-2-1-3-5-16/h1-9,11,13-14,19,21,29H,10,12H2,(H,28,30)(H,31,32)(H,25,26,27)/t19?,21-/m1/s1	LFUNXGUBOACXLA-VGAJERRHSA-N	459243	US10759813, Example 11-9	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459243&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969860	441290505					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948817	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cnc2nn[nH]c2c1)C(O)=O	InChI=1S/C23H21N5O4/c29-20(23(31)32)12-18(25-22(30)17-11-19-21(24-13-17)27-28-26-19)10-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-9,11,13,18,20,29H,10,12H2,(H,25,30)(H,31,32)(H,24,26,27,28)/t18?,20-/m1/s1	SVARUAZNMBELHO-ROPPNANJSA-N	459244	US10759813, Example 11-11	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459244	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459244&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969387	441290506					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948818	O[C@@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cnc2[nH]nnc2c1)C(O)=O	InChI=1S/C23H21N5O4/c29-20(23(31)32)12-18(25-22(30)17-11-19-21(24-13-17)27-28-26-19)10-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-9,11,13,18,20,29H,10,12H2,(H,25,30)(H,31,32)(H,24,26,27,28)/t18-,20+/m1/s1	SVARUAZNMBELHO-QUCCMNQESA-N	459245	US10759813, Example 11-13	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459245&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969940	441290507					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948819	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cnc2[nH]nnc2c1)C(O)=O	InChI=1S/C23H21N5O4/c29-20(23(31)32)12-18(25-22(30)17-11-19-21(24-13-17)27-28-26-19)10-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-9,11,13,18,20,29H,10,12H2,(H,25,30)(H,31,32)(H,24,26,27,28)/t18-,20-/m1/s1	SVARUAZNMBELHO-UYAOXDASSA-N	459246	US10759813, Example 11-15	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459246&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969704	441290508					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948820	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1ccc(o1)C(O)=O)C(O)=O	InChI=1S/C23H21NO7/c25-18(22(27)28)13-17(24-21(26)19-10-11-20(31-19)23(29)30)12-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-11,17-18,25H,12-13H2,(H,24,26)(H,27,28)(H,29,30)/t17-,18?/m1/s1	VWDHMEOJXCQBKQ-QNSVNVJESA-N	459247	US10759813, Example 12-1	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459247	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459247&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67977224	441290509					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948821	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1ccc(s1)C(O)=O)C(O)=O	InChI=1S/C23H21NO6S/c25-18(22(27)28)13-17(24-21(26)19-10-11-20(31-19)23(29)30)12-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-11,17-18,25H,12-13H2,(H,24,26)(H,27,28)(H,29,30)/t17-,18?/m1/s1	BMYKBYNRCDKQKN-QNSVNVJESA-N	459248	US10759813, Example 12-2	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459248	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459248&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961968	441290510					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948822	COc1cc(on1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C22H22N2O6/c1-29-20-13-19(30-24-20)21(26)23-17(12-18(25)22(27)28)11-14-7-9-16(10-8-14)15-5-3-2-4-6-15/h2-10,13,17-18,25H,11-12H2,1H3,(H,23,26)(H,27,28)/t17-,18-/m1/s1	JQYALMZYFSFYMY-QZTJIDSGSA-N	459249	US10759813, Example 12-3	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459249&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67974598	441290511					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948823	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(no1)-c1ccc(Cl)cc1)C(O)=O	InChI=1S/C27H23ClN2O5/c28-21-12-10-20(11-13-21)23-16-25(35-30-23)26(32)29-22(15-24(31)27(33)34)14-17-6-8-19(9-7-17)18-4-2-1-3-5-18/h1-13,16,22,24,31H,14-15H2,(H,29,32)(H,33,34)/t22-,24-/m1/s1	PCRGHRSXTNCFMN-ISKFKSNPSA-N	459250	US10759813, Example 12-4	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459250&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961791	441290512					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948824	COc1ccccc1C(=O)Nc1cc(on1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C29H27N3O7/c1-38-24-10-6-5-9-22(24)27(34)31-26-17-25(39-32-26)28(35)30-21(16-23(33)29(36)37)15-18-11-13-20(14-12-18)19-7-3-2-4-8-19/h2-14,17,21,23,33H,15-16H2,1H3,(H,30,35)(H,36,37)(H,31,32,34)/t21-,23-/m1/s1	JPILZDWJZXPRGI-FYYLOGMGSA-N	459251	US10759813, Example 12-5	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459251&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969621	441290513					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948825	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(no1)-c1ccccc1Cl)C(O)=O	InChI=1S/C27H23ClN2O5/c28-22-9-5-4-8-21(22)23-16-25(35-30-23)26(32)29-20(15-24(31)27(33)34)14-17-10-12-19(13-11-17)18-6-2-1-3-7-18/h1-13,16,20,24,31H,14-15H2,(H,29,32)(H,33,34)/t20-,24-/m1/s1	PLRKEDRKQVRTBL-HYBUGGRVSA-N	459252	US10759813, Example 12-6	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459252&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961892	441290514					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948826	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(no1)C1CCCCC1)C(O)=O	InChI=1S/C27H30N2O5/c30-24(27(32)33)16-22(15-18-11-13-20(14-12-18)19-7-3-1-4-8-19)28-26(31)25-17-23(29-34-25)21-9-5-2-6-10-21/h1,3-4,7-8,11-14,17,21-22,24,30H,2,5-6,9-10,15-16H2,(H,28,31)(H,32,33)/t22-,24-/m1/s1	GESUKNRUWNYTOC-ISKFKSNPSA-N	459253	US10759813, Example 12-7	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459253	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459253&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89962476	441290515					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948827	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(no1)-c1cccc(F)c1)C(O)=O	InChI=1S/C27H23FN2O5/c28-21-8-4-7-20(14-21)23-16-25(35-30-23)26(32)29-22(15-24(31)27(33)34)13-17-9-11-19(12-10-17)18-5-2-1-3-6-18/h1-12,14,16,22,24,31H,13,15H2,(H,29,32)(H,33,34)/t22-,24-/m1/s1	MTPYMAITSUINQM-ISKFKSNPSA-N	459254	US10759813, Example 12-8	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459254	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459254&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961908	441290516					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948828	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(no1)-c1ccccc1F)C(O)=O	InChI=1S/C27H23FN2O5/c28-22-9-5-4-8-21(22)23-16-25(35-30-23)26(32)29-20(15-24(31)27(33)34)14-17-10-12-19(13-11-17)18-6-2-1-3-7-18/h1-13,16,20,24,31H,14-15H2,(H,29,32)(H,33,34)/t20-,24-/m1/s1	HYOLNGLGIFENQD-HYBUGGRVSA-N	459255	US10759813, Example 12-9	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459255	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459255&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961858	441290517					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948829	Cn1cc(cn1)-c1cc(on1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C25H24N4O5/c1-29-15-19(14-26-29)21-13-23(34-28-21)24(31)27-20(12-22(30)25(32)33)11-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h2-10,13-15,20,22,30H,11-12H2,1H3,(H,27,31)(H,32,33)/t20-,22-/m1/s1	ZPKLZTPDUQWLOE-IFMALSPDSA-N	459256	US10759813, Example 12-10	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459256&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969529	441290518					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948830	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(no1)-c1cc(Cl)ccc1Cl)C(O)=O	InChI=1S/C27H22Cl2N2O5/c28-19-10-11-22(29)21(13-19)23-15-25(36-31-23)26(33)30-20(14-24(32)27(34)35)12-16-6-8-18(9-7-16)17-4-2-1-3-5-17/h1-11,13,15,20,24,32H,12,14H2,(H,30,33)(H,34,35)/t20-,24-/m1/s1	GJBSHPLHAJMZPE-HYBUGGRVSA-N	459257	US10759813, Example 12-11	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459257&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961998	441290519					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948831	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(no1)-c1ccc(Cl)c(Cl)c1)C(O)=O	InChI=1S/C27H22Cl2N2O5/c28-21-11-10-19(13-22(21)29)23-15-25(36-31-23)26(33)30-20(14-24(32)27(34)35)12-16-6-8-18(9-7-16)17-4-2-1-3-5-17/h1-11,13,15,20,24,32H,12,14H2,(H,30,33)(H,34,35)/t20-,24-/m1/s1	YECJRFPHIUFBIR-HYBUGGRVSA-N	459258	US10759813, Example 12-12	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459258	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459258&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961985	441290520					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948832	COc1ccccc1-c1cc(on1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C28H26N2O6/c1-35-25-10-6-5-9-22(25)23-17-26(36-30-23)27(32)29-21(16-24(31)28(33)34)15-18-11-13-20(14-12-18)19-7-3-2-4-8-19/h2-14,17,21,24,31H,15-16H2,1H3,(H,29,32)(H,33,34)/t21-,24-/m1/s1	AMJIHKBUBSFMIT-ZJSXRUAMSA-N	459259	US10759813, Example 12-13	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459259	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459259&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67970011	441290521					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948833	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(no1)C(O)=O)C(O)=O	InChI=1S/C22H20N2O7/c25-18(22(29)30)11-16(23-20(26)19-12-17(21(27)28)24-31-19)10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9,12,16,18,25H,10-11H2,(H,23,26)(H,27,28)(H,29,30)/t16-,18-/m1/s1	SNGDVJDKMLMMHN-SJLPKXTDSA-N	459260	US10759813, Example 12-14	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459260	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459260&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969339	441290522					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948834	COc1ccccc1-c1cc(no1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C28H26N2O6/c1-35-25-10-6-5-9-22(25)26-17-23(30-36-26)27(32)29-21(16-24(31)28(33)34)15-18-11-13-20(14-12-18)19-7-3-2-4-8-19/h2-14,17,21,24,31H,15-16H2,1H3,(H,29,32)(H,33,34)/t21-,24-/m1/s1	LHTWSXYFZPHKGC-ZJSXRUAMSA-N	459261	US10759813, Example 12-15	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459261&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969408	441290523					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948835	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(on1)-c1ccccc1Cl)C(O)=O	InChI=1S/C27H23ClN2O5/c28-22-9-5-4-8-21(22)25-16-23(30-35-25)26(32)29-20(15-24(31)27(33)34)14-17-10-12-19(13-11-17)18-6-2-1-3-7-18/h1-13,16,20,24,31H,14-15H2,(H,29,32)(H,33,34)/t20-,24-/m1/s1	OKCSGWZUZUMEQZ-HYBUGGRVSA-N	459262	US10759813, Example 12-16	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459262&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961970	441290524					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948836	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(on1)-c1ccc(Cl)cc1)C(O)=O	InChI=1S/C27H23ClN2O5/c28-21-12-10-20(11-13-21)25-16-23(30-35-25)26(32)29-22(15-24(31)27(33)34)14-17-6-8-19(9-7-17)18-4-2-1-3-5-18/h1-13,16,22,24,31H,14-15H2,(H,29,32)(H,33,34)/t22-,24-/m1/s1	FQULHTSCUASSPQ-ISKFKSNPSA-N	459263	US10759813, Example 12-17	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459263&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961880	441290525					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948837	COc1cccc(c1)-c1cc(no1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C28H26N2O6/c1-35-23-9-5-8-21(15-23)26-17-24(30-36-26)27(32)29-22(16-25(31)28(33)34)14-18-10-12-20(13-11-18)19-6-3-2-4-7-19/h2-13,15,17,22,25,31H,14,16H2,1H3,(H,29,32)(H,33,34)/t22-,25-/m1/s1	BQLFMVNUBIBNLQ-RCZVLFRGSA-N	459264	US10759813, Example 12-18	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459264&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89962089	441290526					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948838	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(CN2CCOCC2)on1)C(O)=O	InChI=1S/C26H29N3O6/c30-24(26(32)33)15-21(14-18-6-8-20(9-7-18)19-4-2-1-3-5-19)27-25(31)23-16-22(35-28-23)17-29-10-12-34-13-11-29/h1-9,16,21,24,30H,10-15,17H2,(H,27,31)(H,32,33)/t21-,24-/m1/s1	OQJAGMBYEXKJLF-ZJSXRUAMSA-N	459265	US10759813, Example 12-19	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459265	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459265&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67970006	441290527					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948839	COc1ccc(cc1)-c1cc(no1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C28H26N2O6/c1-35-23-13-11-21(12-14-23)26-17-24(30-36-26)27(32)29-22(16-25(31)28(33)34)15-18-7-9-20(10-8-18)19-5-3-2-4-6-19/h2-14,17,22,25,31H,15-16H2,1H3,(H,29,32)(H,33,34)/t22-,25-/m1/s1	YSXGHFWKOCZJBO-RCZVLFRGSA-N	459266	US10759813, Example 12-20	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459266&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969741	441290528					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948840	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(on1)-c1ccccc1O)C(O)=O	InChI=1S/C27H24N2O6/c30-23-9-5-4-8-21(23)25-16-22(29-35-25)26(32)28-20(15-24(31)27(33)34)14-17-10-12-19(13-11-17)18-6-2-1-3-7-18/h1-13,16,20,24,30-31H,14-15H2,(H,28,32)(H,33,34)/t20-,24-/m1/s1	YYWWWBVYIXDUGA-HYBUGGRVSA-N	459267	US10759813, Example 12-21	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459267&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			136480942	441290529					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948841	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(NC(=O)c2ccccc2Cl)on1)C(O)=O	InChI=1S/C28H24ClN3O6/c29-22-9-5-4-8-21(22)26(34)31-25-16-23(32-38-25)27(35)30-20(15-24(33)28(36)37)14-17-10-12-19(13-11-17)18-6-2-1-3-7-18/h1-13,16,20,24,33H,14-15H2,(H,30,35)(H,31,34)(H,36,37)/t20-,24-/m1/s1	GYTUIIIISXPVRN-HYBUGGRVSA-N	459268	US10759813, Example 12-22	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459268&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961983	441290530					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948842	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cnc(o1)-c1ccccc1)C(O)=O	InChI=1S/C27H24N2O5/c30-23(27(32)33)16-22(15-18-11-13-20(14-12-18)19-7-3-1-4-8-19)29-25(31)24-17-28-26(34-24)21-9-5-2-6-10-21/h1-14,17,22-23,30H,15-16H2,(H,29,31)(H,32,33)/t22-,23-/m1/s1	OEQMNVURNLWJEO-DHIUTWEWSA-N	459269	US10759813, Example 12-23	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459269&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961784	441290531					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948843	CC(=O)Nc1ncc(s1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C23H23N3O5S/c1-14(27)25-23-24-13-20(32-23)21(29)26-18(12-19(28)22(30)31)11-15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-10,13,18-19,28H,11-12H2,1H3,(H,26,29)(H,30,31)(H,24,25,27)/t18-,19-/m1/s1	VPAIBFGLZPAYJC-RTBURBONSA-N	459270	US10759813, Example 12-24	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459270&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961888	441290532					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948844	COc1ccccc1C(=O)Nc1nc(cs1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C29H27N3O6S/c1-38-25-10-6-5-9-22(25)26(34)32-29-31-23(17-39-29)27(35)30-21(16-24(33)28(36)37)15-18-11-13-20(14-12-18)19-7-3-2-4-8-19/h2-14,17,21,24,33H,15-16H2,1H3,(H,30,35)(H,36,37)(H,31,32,34)/t21-,24-/m1/s1	ZYCCQBIIGULYPV-ZJSXRUAMSA-N	459271	US10759813, Example 12-25	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459271&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			88536464	441290533					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948845	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1nc(no1)-c1ccccc1Cl)C(O)=O	InChI=1S/C26H22ClN3O5/c27-21-9-5-4-8-20(21)23-29-25(35-30-23)24(32)28-19(15-22(31)26(33)34)14-16-10-12-18(13-11-16)17-6-2-1-3-7-17/h1-13,19,22,31H,14-15H2,(H,28,32)(H,33,34)/t19-,22-/m1/s1	UFJUFTXCKCAUHZ-DENIHFKCSA-N	459272	US10759813, Example 12-26	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459272&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969432	441290534					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948846	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1noc(=O)[nH]1)C(O)=O	InChI=1S/C20H19N3O6/c24-16(19(26)27)11-15(21-18(25)17-22-20(28)29-23-17)10-12-6-8-14(9-7-12)13-4-2-1-3-5-13/h1-9,15-16,24H,10-11H2,(H,21,25)(H,26,27)(H,22,23,28)/t15-,16-/m1/s1	VGARUJKSWDXATI-HZPDHXFCSA-N	459273	US10759813, Example 12-27	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459273&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903412	441290535					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948847	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cnc(cn1)C(O)=O)C(O)=O	InChI=1S/C23H21N3O6/c27-20(23(31)32)11-17(26-21(28)18-12-25-19(13-24-18)22(29)30)10-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-9,12-13,17,20,27H,10-11H2,(H,26,28)(H,29,30)(H,31,32)/t17-,20?/m1/s1	VLZOHZGUCUAGQR-DIAVIDTQSA-N	459274	US10759813, Example 13-1	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459274&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961935	441290536					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948848	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1ccc(nn1)C(O)=O)C(O)=O	InChI=1S/C23H21N3O6/c27-20(23(31)32)13-17(24-21(28)18-10-11-19(22(29)30)26-25-18)12-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-11,17,20,27H,12-13H2,(H,24,28)(H,29,30)(H,31,32)/t17-,20?/m1/s1	JQITXEBRHGOUSD-DIAVIDTQSA-N	459275	US10759813, Example 13-3	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459275	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459275&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969658	441290537					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948849	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1ccc(O)nn1)C(O)=O	InChI=1S/C22H21N3O5/c26-19(22(29)30)13-17(23-21(28)18-10-11-20(27)25-24-18)12-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-11,17,19,26H,12-13H2,(H,23,28)(H,25,27)(H,29,30)/t17?,19-/m1/s1	HDMVVNZWINRBOE-WHCXFUJUSA-N	459276	US10759813, Example 13-5	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459276&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961885	441290538					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948850	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)C1=NNC(=O)CC1)C(O)=O	InChI=1S/C22H23N3O5/c26-19(22(29)30)13-17(23-21(28)18-10-11-20(27)25-24-18)12-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-9,17,19,26H,10-13H2,(H,23,28)(H,25,27)(H,29,30)/t17?,19-/m1/s1	WGMJZEPWKOZJOO-WHCXFUJUSA-N	459277	US10759813, Example 13-6	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459277	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459277&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969648	441290539					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948851	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1ccc(cn1)C(O)=O)C(O)=O	InChI=1S/C24H22N2O6/c27-21(24(31)32)13-19(26-22(28)20-11-10-18(14-25-20)23(29)30)12-15-6-8-17(9-7-15)16-4-2-1-3-5-16/h1-11,14,19,21,27H,12-13H2,(H,26,28)(H,29,30)(H,31,32)/t19-,21?/m1/s1	RLEHCFIHENFEAD-YMBRHYMPSA-N	459278	US10759813, Example 13-7	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459278	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459278&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969857	441290540					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948852	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1ccc(nc1)C(O)=O)C(O)=O	InChI=1S/C24H22N2O6/c27-21(24(31)32)13-19(26-22(28)18-10-11-20(23(29)30)25-14-18)12-15-6-8-17(9-7-15)16-4-2-1-3-5-16/h1-11,14,19,21,27H,12-13H2,(H,26,28)(H,29,30)(H,31,32)/t19-,21?/m1/s1	RSFJHVBVOSANCO-YMBRHYMPSA-N	459279	US10759813, Example 13-8	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459279	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459279&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961898	441290541					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948853	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1nnn[nH]1)C(O)=O	InChI=1S/C19H19N5O4/c25-16(19(27)28)11-15(20-18(26)17-21-23-24-22-17)10-12-6-8-14(9-7-12)13-4-2-1-3-5-13/h1-9,15-16,25H,10-11H2,(H,20,26)(H,27,28)(H,21,22,23,24)/t15?,16-/m1/s1	OTVIGTRDSAFYRX-OEMAIJDKSA-N	459280	US10759813, Example 14	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459280&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903413	441290542					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948854	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc[nH]n1)C(O)=O	InChI=1S/C21H21N3O4/c25-19(21(27)28)13-17(23-20(26)18-10-11-22-24-18)12-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-11,17,19,25H,12-13H2,(H,22,24)(H,23,26)(H,27,28)/t17?,19-/m1/s1	DXPLSBXVZDRUCT-WHCXFUJUSA-N	459281	US10759813, Example 15-1	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459281	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459281&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903414	441290543					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948855	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(CC(O)=O)[nH]n1)C(O)=O	InChI=1S/C23H23N3O6/c27-20(23(31)32)12-17(24-22(30)19-11-18(25-26-19)13-21(28)29)10-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-9,11,17,20,27H,10,12-13H2,(H,24,30)(H,25,26)(H,28,29)(H,31,32)/t17-,20-/m1/s1	SYJWQZSBEBXKLR-YLJYHZDGSA-N	459282	US10759813, Example 15-2	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459282	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459282&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903415	441290544					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948856	OCc1cc(n[nH]1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C22H23N3O5/c26-13-18-11-19(25-24-18)21(28)23-17(12-20(27)22(29)30)10-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-9,11,17,20,26-27H,10,12-13H2,(H,23,28)(H,24,25)(H,29,30)/t17-,20-/m1/s1	YGBPAKIEJNOKJB-YLJYHZDGSA-N	459283	US10759813, Example 15-3	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459283&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903416	441290545					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948857	COCc1cc(n[nH]1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C23H25N3O5/c1-31-14-19-12-20(26-25-19)22(28)24-18(13-21(27)23(29)30)11-15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-10,12,18,21,27H,11,13-14H2,1H3,(H,24,28)(H,25,26)(H,29,30)/t18-,21-/m1/s1	GQJASQQUHKBNSB-WIYYLYMNSA-N	459284	US10759813, Example 15-4	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459284	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459284&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903417	441290546					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948858	Cn1nc(cc1C(O)=O)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C23H23N3O6/c1-26-19(22(29)30)13-18(25-26)21(28)24-17(12-20(27)23(31)32)11-14-7-9-16(10-8-14)15-5-3-2-4-6-15/h2-10,13,17,20,27H,11-12H2,1H3,(H,24,28)(H,29,30)(H,31,32)/t17-,20-/m1/s1	XTPSJUFNDWCPHA-YLJYHZDGSA-N	459285	US10759813, Example 15-5	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459285	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459285&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67970084	441290547					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948859	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(C(O)=O)n(Cc2ccc(Cl)c(SC(F)(F)F)c2)n1)C(O)=O	InChI=1S/C30H25ClF3N3O6S/c31-22-11-8-18(13-26(22)44-30(32,33)34)16-37-24(28(40)41)15-23(36-37)27(39)35-21(14-25(38)29(42)43)12-17-6-9-20(10-7-17)19-4-2-1-3-5-19/h1-11,13,15,21,25,38H,12,14,16H2,(H,35,39)(H,40,41)(H,42,43)/t21-,25?/m1/s1	GLHMRPYQAGCJLC-JGKWMGOWSA-N	459286	US10759813, Example 15-6	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459286	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459286&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969684	441290548					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948860	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(C(O)=O)n(Cc2cccc(Cl)c2)n1)C(O)=O	InChI=1S/C29H26ClN3O6/c30-22-8-4-5-19(13-22)17-33-25(28(36)37)16-24(32-33)27(35)31-23(15-26(34)29(38)39)14-18-9-11-21(12-10-18)20-6-2-1-3-7-20/h1-13,16,23,26,34H,14-15,17H2,(H,31,35)(H,36,37)(H,38,39)/t23-,26?/m1/s1	UHUCIRYMCFTBOJ-GEPVFLLWSA-N	459287	US10759813, Example 15-7	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459287&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969625	441290549					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948861	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(C(O)=O)n(Cc2c(F)cc(Cl)cc2F)n1)C(O)=O	InChI=1S/C29H24ClF2N3O6/c30-19-11-22(31)21(23(32)12-19)15-35-25(28(38)39)14-24(34-35)27(37)33-20(13-26(36)29(40)41)10-16-6-8-18(9-7-16)17-4-2-1-3-5-17/h1-9,11-12,14,20,26,36H,10,13,15H2,(H,33,37)(H,38,39)(H,40,41)/t20-,26?/m1/s1	KNTJMRVKTABRJY-TUHVGIAZSA-N	459288	US10759813, Example 15-8	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459288&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969890	441290550					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948862	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(C(O)=O)n(Cc2ccccc2Cl)n1)C(O)=O	InChI=1S/C29H26ClN3O6/c30-23-9-5-4-8-21(23)17-33-25(28(36)37)16-24(32-33)27(35)31-22(15-26(34)29(38)39)14-18-10-12-20(13-11-18)19-6-2-1-3-7-19/h1-13,16,22,26,34H,14-15,17H2,(H,31,35)(H,36,37)(H,38,39)/t22-,26?/m1/s1	RLXMJPFWQGXAQI-FPSALIRRSA-N	459289	US10759813, Example 15-9	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459289&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969507	441290551					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948863	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(C(O)=O)n(Cc2cc(F)ccc2Cl)n1)C(O)=O	InChI=1S/C29H25ClFN3O6/c30-23-11-10-21(31)13-20(23)16-34-25(28(37)38)15-24(33-34)27(36)32-22(14-26(35)29(39)40)12-17-6-8-19(9-7-17)18-4-2-1-3-5-18/h1-11,13,15,22,26,35H,12,14,16H2,(H,32,36)(H,37,38)(H,39,40)/t22-,26?/m1/s1	XVIKWONXXHKNER-FPSALIRRSA-N	459290	US10759813, Example 15-10	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459290	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459290&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961687	441290552					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948864	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(C(O)=O)n(Cc2cc(F)cc(Cl)c2)n1)C(O)=O	InChI=1S/C29H25ClFN3O6/c30-21-10-18(11-22(31)13-21)16-34-25(28(37)38)15-24(33-34)27(36)32-23(14-26(35)29(39)40)12-17-6-8-20(9-7-17)19-4-2-1-3-5-19/h1-11,13,15,23,26,35H,12,14,16H2,(H,32,36)(H,37,38)(H,39,40)/t23-,26?/m1/s1	UFZMKAIOWHYHNF-GEPVFLLWSA-N	459291	US10759813, Example 15-11	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459291&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961797	441290553					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948865	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(C(O)=O)n(Cc2ccc(Cl)c(OC(F)(F)F)c2)n1)C(O)=O	InChI=1S/C30H25ClF3N3O7/c31-22-11-8-18(13-26(22)44-30(32,33)34)16-37-24(28(40)41)15-23(36-37)27(39)35-21(14-25(38)29(42)43)12-17-6-9-20(10-7-17)19-4-2-1-3-5-19/h1-11,13,15,21,25,38H,12,14,16H2,(H,35,39)(H,40,41)(H,42,43)/t21-,25?/m1/s1	OMJCUCFEDAKQDR-JGKWMGOWSA-N	459292	US10759813, Example 15-12	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459292	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459292&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969281	441290554					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948866	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(C(O)=O)n(Cc2ccc(Cl)cc2F)n1)C(O)=O	InChI=1S/C29H25ClFN3O6/c30-21-11-10-20(23(31)13-21)16-34-25(28(37)38)15-24(33-34)27(36)32-22(14-26(35)29(39)40)12-17-6-8-19(9-7-17)18-4-2-1-3-5-18/h1-11,13,15,22,26,35H,12,14,16H2,(H,32,36)(H,37,38)(H,39,40)/t22-,26?/m1/s1	USUFASNPTOOQAZ-FPSALIRRSA-N	459293	US10759813, Example 15-13	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459293	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459293&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969435	441290555					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948867	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(C(O)=O)n(Cc2ccc(F)c(Cl)c2)n1)C(O)=O	InChI=1S/C29H25ClFN3O6/c30-22-13-18(8-11-23(22)31)16-34-25(28(37)38)15-24(33-34)27(36)32-21(14-26(35)29(39)40)12-17-6-9-20(10-7-17)19-4-2-1-3-5-19/h1-11,13,15,21,26,35H,12,14,16H2,(H,32,36)(H,37,38)(H,39,40)/t21-,26?/m1/s1	BOAVAYASHIFKHG-OSMGYRLQSA-N	459294	US10759813, Example 15-14	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459294	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459294&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969626	441290556					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948868	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(C(O)=O)n(Cc2ccc(Cl)cc2)n1)C(O)=O	InChI=1S/C29H26ClN3O6/c30-22-12-8-19(9-13-22)17-33-25(28(36)37)16-24(32-33)27(35)31-23(15-26(34)29(38)39)14-18-6-10-21(11-7-18)20-4-2-1-3-5-20/h1-13,16,23,26,34H,14-15,17H2,(H,31,35)(H,36,37)(H,38,39)/t23-,26?/m1/s1	HACPOBZODGWFSJ-GEPVFLLWSA-N	459295	US10759813, Example 15-15	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459295	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459295&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961912	441290557					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948869	OC(C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(C(O)=O)n(Cc2c(F)ccc(Cl)c2F)n1)C(O)=O	InChI=1S/C29H24ClF2N3O6/c30-21-10-11-22(31)20(26(21)32)15-35-24(28(38)39)14-23(34-35)27(37)33-19(13-25(36)29(40)41)12-16-6-8-18(9-7-16)17-4-2-1-3-5-17/h1-11,14,19,25,36H,12-13,15H2,(H,33,37)(H,38,39)(H,40,41)/t19-,25?/m1/s1	LXXNNOZWYPHZSD-OEPVSBQMSA-N	459296	US10759813, Example 15-16	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459296	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459296&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969634	441290558					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948870	COc1cccc(Cn2nc(cc2C(O)=O)C(=O)N[C@@H](CC(O)C(O)=O)Cc2ccc(cc2)-c2ccccc2)c1	InChI=1S/C30H29N3O7/c1-40-24-9-5-6-20(15-24)18-33-26(29(36)37)17-25(32-33)28(35)31-23(16-27(34)30(38)39)14-19-10-12-22(13-11-19)21-7-3-2-4-8-21/h2-13,15,17,23,27,34H,14,16,18H2,1H3,(H,31,35)(H,36,37)(H,38,39)/t23-,27?/m1/s1	XKXFNCOSEGEPGG-BRIWLPCBSA-N	459297	US10759813, Example 15-17	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459297&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969948	441290559					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948871	Cc1cc(n[nH]1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C22H23N3O4/c1-14-11-19(25-24-14)21(27)23-18(13-20(26)22(28)29)12-15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-11,18,20,26H,12-13H2,1H3,(H,23,27)(H,24,25)(H,28,29)/t18?,20-/m1/s1	CFLBSKXQQRHAMX-ROPPNANJSA-N	459298	US10759813, Example 15-19	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459298	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459298&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903418	441290560					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948872	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)-c1ccncc1)C(O)=O	InChI=1S/C26H24N4O4/c31-24(26(33)34)15-21(14-17-6-8-19(9-7-17)18-4-2-1-3-5-18)28-25(32)23-16-22(29-30-23)20-10-12-27-13-11-20/h1-13,16,21,24,31H,14-15H2,(H,28,32)(H,29,30)(H,33,34)/t21-,24-/m1/s1	HHWGDTSWFYWEID-ZJSXRUAMSA-N	459299	US10759813, Example 15-20	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459299	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459299&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903419	441290561					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948873	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)-c1cccnc1)C(O)=O	InChI=1S/C26H24N4O4/c31-24(26(33)34)14-21(13-17-8-10-19(11-9-17)18-5-2-1-3-6-18)28-25(32)23-15-22(29-30-23)20-7-4-12-27-16-20/h1-12,15-16,21,24,31H,13-14H2,(H,28,32)(H,29,30)(H,33,34)/t21-,24-/m1/s1	BXYUYALUVQJJBE-ZJSXRUAMSA-N	459300	US10759813, Example 15-21	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459300	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459300&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903420	441290562					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948874	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)-c1cnccn1)C(O)=O	InChI=1S/C25H23N5O4/c31-23(25(33)34)13-19(12-16-6-8-18(9-7-16)17-4-2-1-3-5-17)28-24(32)21-14-20(29-30-21)22-15-26-10-11-27-22/h1-11,14-15,19,23,31H,12-13H2,(H,28,32)(H,29,30)(H,33,34)/t19?,23-/m1/s1	PIPIRKUSVIBCNP-LEQGEALCSA-N	459301	US10759813, Example 15-22	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459301&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903421	441290563					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948875	Cn1cc(cn1)-c1cc(n[nH]1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C25H25N5O4/c1-30-15-19(14-26-30)21-13-22(29-28-21)24(32)27-20(12-23(31)25(33)34)11-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h2-10,13-15,20,23,31H,11-12H2,1H3,(H,27,32)(H,28,29)(H,33,34)/t20?,23-/m1/s1	DMGDXEOOCNENPA-GWQXNCQPSA-N	459302	US10759813, Example 15-23	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459302	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459302&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903422	441290564					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948876	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)-c1ccccc1Cl)C(O)=O	InChI=1S/C27H24ClN3O4/c28-22-9-5-4-8-21(22)23-16-24(31-30-23)26(33)29-20(15-25(32)27(34)35)14-17-10-12-19(13-11-17)18-6-2-1-3-7-18/h1-13,16,20,25,32H,14-15H2,(H,29,33)(H,30,31)(H,34,35)/t20?,25-/m1/s1	JDYIJBGFSSDJKO-GBAXHLBXSA-N	459303	US10759813, Example 15-24	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459303	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459303&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903423	441290565					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948877	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)-c1cccc(Cl)c1)C(O)=O	InChI=1S/C27H24ClN3O4/c28-21-8-4-7-20(14-21)23-16-24(31-30-23)26(33)29-22(15-25(32)27(34)35)13-17-9-11-19(12-10-17)18-5-2-1-3-6-18/h1-12,14,16,22,25,32H,13,15H2,(H,29,33)(H,30,31)(H,34,35)/t22-,25-/m1/s1	XKVLSSFCDNMOKV-RCZVLFRGSA-N	459304	US10759813, Example 15-25	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459304	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459304&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903424	441290566					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948878	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)-c1ccc(Cl)cc1Cl)C(O)=O	InChI=1S/C27H23Cl2N3O4/c28-19-10-11-21(22(29)13-19)23-15-24(32-31-23)26(34)30-20(14-25(33)27(35)36)12-16-6-8-18(9-7-16)17-4-2-1-3-5-17/h1-11,13,15,20,25,33H,12,14H2,(H,30,34)(H,31,32)(H,35,36)/t20-,25-/m1/s1	JPDGYTXNVNOFCY-CJFMBICVSA-N	459305	US10759813, Example 15-26	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459305	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459305&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903425	441290567					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948879	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)-c1cc(Cl)ccc1Cl)C(O)=O	InChI=1S/C27H23Cl2N3O4/c28-19-10-11-22(29)21(13-19)23-15-24(32-31-23)26(34)30-20(14-25(33)27(35)36)12-16-6-8-18(9-7-16)17-4-2-1-3-5-17/h1-11,13,15,20,25,33H,12,14H2,(H,30,34)(H,31,32)(H,35,36)/t20-,25-/m1/s1	ZRCJXARGEVAXDO-CJFMBICVSA-N	459306	US10759813, Example 15-27	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459306	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459306&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903426	441290568					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948880	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)-c1ccccc1O)C(O)=O	InChI=1S/C27H25N3O5/c31-24-9-5-4-8-21(24)22-16-23(30-29-22)26(33)28-20(15-25(32)27(34)35)14-17-10-12-19(13-11-17)18-6-2-1-3-7-18/h1-13,16,20,25,31-32H,14-15H2,(H,28,33)(H,29,30)(H,34,35)/t20-,25-/m1/s1	KAWHAMFZWPWXNI-CJFMBICVSA-N	459307	US10759813, Example 15-28	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459307	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459307&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903427	441290569					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948881	OCC(O)Cn1nc(cc1-c1ccccc1O)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C30H31N3O7/c34-18-23(35)17-33-26(24-8-4-5-9-27(24)36)16-25(32-33)29(38)31-22(15-28(37)30(39)40)14-19-10-12-21(13-11-19)20-6-2-1-3-7-20/h1-13,16,22-23,28,34-37H,14-15,17-18H2,(H,31,38)(H,39,40)/t22-,23?,28-/m1/s1	ZZYCFKOSKUZRLI-LYHAXUCYSA-N	459308	US10759813, Example 15-30	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459308	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459308&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			136621644	441290570					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948882	CC(=O)Nc1cccc(c1)-c1cc(n[nH]1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C29H28N4O5/c1-18(34)30-23-9-5-8-22(15-23)25-17-26(33-32-25)28(36)31-24(16-27(35)29(37)38)14-19-10-12-21(13-11-19)20-6-3-2-4-7-20/h2-13,15,17,24,27,35H,14,16H2,1H3,(H,30,34)(H,31,36)(H,32,33)(H,37,38)/t24?,27-/m1/s1	MAIFJHWWFYQALB-LFHRXCRSSA-N	459309	US10759813, Example 15-31	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459309	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459309&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903428	441290571					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948883	COc1ccccc1C(=O)Nc1cc(n[nH]1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C29H28N4O6/c1-39-25-10-6-5-9-22(25)27(35)31-26-17-23(32-33-26)28(36)30-21(16-24(34)29(37)38)15-18-11-13-20(14-12-18)19-7-3-2-4-8-19/h2-14,17,21,24,34H,15-16H2,1H3,(H,30,36)(H,37,38)(H2,31,32,33,35)/t21-,24-/m1/s1	XCQXWKMCIDKMQO-ZJSXRUAMSA-N	459310	US10759813, Example 15-32	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459310	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459310&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903429	441290572					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948884	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)-c1ccccc1)C(O)=O	InChI=1S/C27H25N3O4/c31-25(27(33)34)16-22(15-18-11-13-20(14-12-18)19-7-3-1-4-8-19)28-26(32)24-17-23(29-30-24)21-9-5-2-6-10-21/h1-14,17,22,25,31H,15-16H2,(H,28,32)(H,29,30)(H,33,34)/t22-,25-/m1/s1	ILZQVFHIMPFPPI-RCZVLFRGSA-N	459311	US10759813, Example 15-33	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459311	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459311&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903430	441290573					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948885	Cn1nc(cc1-c1ccccc1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C28H27N3O4/c1-31-25(22-10-6-3-7-11-22)18-24(30-31)27(33)29-23(17-26(32)28(34)35)16-19-12-14-21(15-13-19)20-8-4-2-5-9-20/h2-15,18,23,26,32H,16-17H2,1H3,(H,29,33)(H,34,35)/t23?,26-/m1/s1	YOLLKFBTKRBDEM-ANWICMFUSA-N	459312	US10759813, Example 15-34	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459312	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459312&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969414	441290574					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948886	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(-c2ccccc2)n(CC(O)=O)n1)C(O)=O	InChI=1S/C29H27N3O6/c33-26(29(37)38)16-23(15-19-11-13-21(14-12-19)20-7-3-1-4-8-20)30-28(36)24-17-25(22-9-5-2-6-10-22)32(31-24)18-27(34)35/h1-14,17,23,26,33H,15-16,18H2,(H,30,36)(H,34,35)(H,37,38)/t23-,26-/m1/s1	HTTZNBHXBHHNKD-ZEQKJWHPSA-N	459313	US10759813, Example 15-35	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459313	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459313&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969395	441290575					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948887	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(-c2ccccc2)n(CCC(O)=O)n1)C(O)=O	InChI=1S/C30H29N3O6/c34-27(30(38)39)18-24(17-20-11-13-22(14-12-20)21-7-3-1-4-8-21)31-29(37)25-19-26(23-9-5-2-6-10-23)33(32-25)16-15-28(35)36/h1-14,19,24,27,34H,15-18H2,(H,31,37)(H,35,36)(H,38,39)/t24-,27-/m1/s1	KYNKKGQSJQOGMU-SHQCIBLASA-N	459314	US10759813, Example 15-36	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459314	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459314&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969462	441290576					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948888	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)-c1ccco1)C(O)=O	InChI=1S/C25H23N3O5/c29-22(25(31)32)14-19(13-16-8-10-18(11-9-16)17-5-2-1-3-6-17)26-24(30)21-15-20(27-28-21)23-7-4-12-33-23/h1-12,15,19,22,29H,13-14H2,(H,26,30)(H,27,28)(H,31,32)/t19?,22-/m1/s1	TZZJPNJQWFDIHL-AVKWCDSFSA-N	459315	US10759813, Example 15-37	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459315	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459315&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903431	441290577					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948889	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)-c1ccc2ccccc2c1)C(O)=O	InChI=1S/C31H27N3O4/c35-29(31(37)38)18-26(16-20-10-12-23(13-11-20)21-6-2-1-3-7-21)32-30(36)28-19-27(33-34-28)25-15-14-22-8-4-5-9-24(22)17-25/h1-15,17,19,26,29,35H,16,18H2,(H,32,36)(H,33,34)(H,37,38)/t26?,29-/m1/s1	ZINQSYNMKSBNPM-BNGNXUGRSA-N	459316	US10759813, Example 15-38	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459316	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459316&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903432	441290578					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948890	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)-c1ccc(cc1)-c1ccccc1)C(O)=O	InChI=1S/C33H29N3O4/c37-31(33(39)40)20-28(19-22-11-13-25(14-12-22)23-7-3-1-4-8-23)34-32(38)30-21-29(35-36-30)27-17-15-26(16-18-27)24-9-5-2-6-10-24/h1-18,21,28,31,37H,19-20H2,(H,34,38)(H,35,36)(H,39,40)/t28?,31-/m1/s1	KIBKLVMQYXVTLB-VPTMLEGASA-N	459317	US10759813, Example 15-39	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459317	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459317&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903433	441290579					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948891	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc([nH]n1)-c1ccc(Cl)cc1)C(O)=O	InChI=1S/C27H24ClN3O4/c28-21-12-10-20(11-13-21)23-16-24(31-30-23)26(33)29-22(15-25(32)27(34)35)14-17-6-8-19(9-7-17)18-4-2-1-3-5-18/h1-13,16,22,25,32H,14-15H2,(H,29,33)(H,30,31)(H,34,35)/t22?,25-/m1/s1	JFFXFTKPDCLOFP-NRWPOFLRSA-N	459318	US10759813, Example 15-40	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459318	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459318&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903434	441290580					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948892	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)C(=O)N1CCC(O)C1)C(O)=O	InChI=1S/C26H28N4O6/c31-20-10-11-30(15-20)25(34)22-14-21(28-29-22)24(33)27-19(13-23(32)26(35)36)12-16-6-8-18(9-7-16)17-4-2-1-3-5-17/h1-9,14,19-20,23,31-32H,10-13,15H2,(H,27,33)(H,28,29)(H,35,36)/t19?,20?,23-/m1/s1	HGZIBRDYKCTMJZ-YABDQXBESA-N	459319	US10759813, Example 15-42	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459319	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459319&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903435	441290581					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948893	NC(=O)C1CCN(C1)C(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C27H29N5O6/c28-24(34)19-10-11-32(15-19)26(36)22-14-21(30-31-22)25(35)29-20(13-23(33)27(37)38)12-16-6-8-18(9-7-16)17-4-2-1-3-5-17/h1-9,14,19-20,23,33H,10-13,15H2,(H2,28,34)(H,29,35)(H,30,31)(H,37,38)/t19?,20-,23+/m1/s1	GWQGQVOWESGRMI-WJJSNJRJSA-N	459320	US10759813, Example 15-44	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459320	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459320&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903436	441290582					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948894	NC(=O)C1CCN(C1)C(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C27H29N5O6/c28-24(34)19-10-11-32(15-19)26(36)22-14-21(30-31-22)25(35)29-20(13-23(33)27(37)38)12-16-6-8-18(9-7-16)17-4-2-1-3-5-17/h1-9,14,19-20,23,33H,10-13,15H2,(H2,28,34)(H,29,35)(H,30,31)(H,37,38)/t19?,20-,23-/m1/s1	GWQGQVOWESGRMI-CXAYOUKQSA-N	459321	US10759813, Example 15-46	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459321	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459321&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903437	441290583					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948895	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)C(=O)N1CCC(O)CC1)C(O)=O	InChI=1S/C27H30N4O6/c32-21-10-12-31(13-11-21)26(35)23-16-22(29-30-23)25(34)28-20(15-24(33)27(36)37)14-17-6-8-19(9-7-17)18-4-2-1-3-5-18/h1-9,16,20-21,24,32-33H,10-15H2,(H,28,34)(H,29,30)(H,36,37)/t20-,24-/m1/s1	QDYHZCIQSKEQCF-HYBUGGRVSA-N	459322	US10759813, Example 15-48	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459322	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459322&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903438	441290584					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948896	O[C@@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)C(=O)N1CCC(O)CC1)C(O)=O	InChI=1S/C27H30N4O6/c32-21-10-12-31(13-11-21)26(35)23-16-22(29-30-23)25(34)28-20(15-24(33)27(36)37)14-17-6-8-19(9-7-17)18-4-2-1-3-5-18/h1-9,16,20-21,24,32-33H,10-15H2,(H,28,34)(H,29,30)(H,36,37)/t20-,24+/m1/s1	QDYHZCIQSKEQCF-YKSBVNFPSA-N	459323	US10759813, Example 15-50	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459323	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459323&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903439	441290585					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948897	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)C(=O)N1CCOCC1)C(O)=O	InChI=1S/C26H28N4O6/c31-23(26(34)35)15-20(14-17-6-8-19(9-7-17)18-4-2-1-3-5-18)27-24(32)21-16-22(29-28-21)25(33)30-10-12-36-13-11-30/h1-9,16,20,23,31H,10-15H2,(H,27,32)(H,28,29)(H,34,35)/t20?,23-/m1/s1	YWJHNGQGXYLEMK-GWQXNCQPSA-N	459324	US10759813, Example 15-53	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459324	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459324&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903440	441290586					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948898	O[C@@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)C(=O)NC1CC1)C(O)=O	InChI=1S/C25H26N4O5/c30-22(25(33)34)13-19(12-15-6-8-17(9-7-15)16-4-2-1-3-5-16)27-24(32)21-14-20(28-29-21)23(31)26-18-10-11-18/h1-9,14,18-19,22,30H,10-13H2,(H,26,31)(H,27,32)(H,28,29)(H,33,34)/t19-,22+/m1/s1	IWUPFWLBGBGXSP-KNQAVFIVSA-N	459325	US10759813, Example 15-55	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459325	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459325&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903441	441290587					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948899	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)C(=O)NCC(O)=O)C(O)=O	InChI=1S/C24H24N4O7/c29-20(24(34)35)11-17(10-14-6-8-16(9-7-14)15-4-2-1-3-5-15)26-23(33)19-12-18(27-28-19)22(32)25-13-21(30)31/h1-9,12,17,20,29H,10-11,13H2,(H,25,32)(H,26,33)(H,27,28)(H,30,31)(H,34,35)/t17?,20-/m1/s1	NQNVMNMWMRBPJJ-UUSAFJCLSA-N	459326	US10759813, Example 15-56	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459326	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459326&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903442	441290588					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948900	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)C(=O)NC1CC1)C(O)=O	InChI=1S/C25H26N4O5/c30-22(25(33)34)13-19(12-15-6-8-17(9-7-15)16-4-2-1-3-5-16)27-24(32)21-14-20(28-29-21)23(31)26-18-10-11-18/h1-9,14,18-19,22,30H,10-13H2,(H,26,31)(H,27,32)(H,28,29)(H,33,34)/t19-,22-/m1/s1	IWUPFWLBGBGXSP-DENIHFKCSA-N	459327	US10759813, Example 15-57	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459327	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459327&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903443	441290589					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948901	NC(=O)c1cc([nH]n1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C22H22N4O5/c23-20(28)17-12-18(26-25-17)21(29)24-16(11-19(27)22(30)31)10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9,12,16,19,27H,10-11H2,(H2,23,28)(H,24,29)(H,25,26)(H,30,31)/t16?,19-/m1/s1	YRLJFEOHEBMJNZ-LRTDYKAYSA-N	459328	US10759813, Example 15-59	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459328	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459328&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903444	441290590					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948902	CNC(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C23H24N4O5/c1-24-21(29)18-13-19(27-26-18)22(30)25-17(12-20(28)23(31)32)11-14-7-9-16(10-8-14)15-5-3-2-4-6-15/h2-10,13,17,20,28H,11-12H2,1H3,(H,24,29)(H,25,30)(H,26,27)(H,31,32)/t17-,20-/m1/s1	OSMLWJTZGFCVIH-YLJYHZDGSA-N	459329	US10759813, Example 15-60	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459329	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459329&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903445	441290591					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948903	CCCNC(=O)c1cc([nH]n1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C25H28N4O5/c1-2-12-26-23(31)20-15-21(29-28-20)24(32)27-19(14-22(30)25(33)34)13-16-8-10-18(11-9-16)17-6-4-3-5-7-17/h3-11,15,19,22,30H,2,12-14H2,1H3,(H,26,31)(H,27,32)(H,28,29)(H,33,34)/t19?,22-/m1/s1	UPFONKCNQIJUPS-AVKWCDSFSA-N	459330	US10759813, Example 15-61	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459330	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459330&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903446	441290592					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948904	CN(C)C(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C24H26N4O5/c1-28(2)23(31)20-14-19(26-27-20)22(30)25-18(13-21(29)24(32)33)12-15-8-10-17(11-9-15)16-6-4-3-5-7-16/h3-11,14,18,21,29H,12-13H2,1-2H3,(H,25,30)(H,26,27)(H,32,33)/t18-,21-/m1/s1	NDGDCALWDPRFEC-WIYYLYMNSA-N	459331	US10759813, Example 15-63	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459331	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459331&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903447	441290593					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948905	CC(C)CN(C)C(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C27H32N4O5/c1-17(2)16-31(3)26(34)23-15-22(29-30-23)25(33)28-21(14-24(32)27(35)36)13-18-9-11-20(12-10-18)19-7-5-4-6-8-19/h4-12,15,17,21,24,32H,13-14,16H2,1-3H3,(H,28,33)(H,29,30)(H,35,36)/t21-,24+/m1/s1	XFBTVXMJWNISJL-QPPBQGQZSA-N	459332	US10759813, Example 15-65	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459332	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459332&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903448	441290594					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948906	CC(C)CN(C)C(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C27H32N4O5/c1-17(2)16-31(3)26(34)23-15-22(29-30-23)25(33)28-21(14-24(32)27(35)36)13-18-9-11-20(12-10-18)19-7-5-4-6-8-19/h4-12,15,17,21,24,32H,13-14,16H2,1-3H3,(H,28,33)(H,29,30)(H,35,36)/t21-,24-/m1/s1	XFBTVXMJWNISJL-ZJSXRUAMSA-N	459333	US10759813, Example 15-67	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459333	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459333&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903449	441290595					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948907	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)C(=O)NCCc1cnc[nH]1)C(O)=O	InChI=1S/C27H28N6O5/c34-24(27(37)38)13-21(12-17-6-8-19(9-7-17)18-4-2-1-3-5-18)31-26(36)23-14-22(32-33-23)25(35)29-11-10-20-15-28-16-30-20/h1-9,14-16,21,24,34H,10-13H2,(H,28,30)(H,29,35)(H,31,36)(H,32,33)(H,37,38)/t21-,24-/m1/s1	HTXJVPKTHLNWKR-ZJSXRUAMSA-N	459334	US10759813, Example 15-69	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459334	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459334&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903450	441290596					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948908	OCCNC(=O)c1cc([nH]n1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C24H26N4O6/c29-11-10-25-22(31)19-14-20(28-27-19)23(32)26-18(13-21(30)24(33)34)12-15-6-8-17(9-7-15)16-4-2-1-3-5-16/h1-9,14,18,21,29-30H,10-13H2,(H,25,31)(H,26,32)(H,27,28)(H,33,34)/t18?,21-/m1/s1	YFFQTDIWFVTPLB-BDPMCISCSA-N	459335	US10759813, Example 15-70	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459335	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459335&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903451	441290597					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948909	CN(C)CCNC(=O)c1cc([nH]n1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C26H31N5O5/c1-31(2)13-12-27-24(33)21-16-22(30-29-21)25(34)28-20(15-23(32)26(35)36)14-17-8-10-19(11-9-17)18-6-4-3-5-7-18/h3-11,16,20,23,32H,12-15H2,1-2H3,(H,27,33)(H,28,34)(H,29,30)(H,35,36)/t20?,23-/m1/s1	KLCTVKDKJBKELJ-GWQXNCQPSA-N	459336	US10759813, Example 15-71	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459336	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459336&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903452	441290598					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948910	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)C1CC1)C(O)=O	InChI=1S/C24H25N3O4/c28-22(24(30)31)13-19(25-23(29)21-14-20(26-27-21)18-10-11-18)12-15-6-8-17(9-7-15)16-4-2-1-3-5-16/h1-9,14,18-19,22,28H,10-13H2,(H,25,29)(H,26,27)(H,30,31)/t19?,22-/m1/s1	FXQYTSLHISCAAU-AVKWCDSFSA-N	459337	US10759813, Example 15-72	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459337	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459337&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903453	441290599					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948911	CC(C)c1cc([nH]n1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C24H27N3O4/c1-15(2)20-14-21(27-26-20)23(29)25-19(13-22(28)24(30)31)12-16-8-10-18(11-9-16)17-6-4-3-5-7-17/h3-11,14-15,19,22,28H,12-13H2,1-2H3,(H,25,29)(H,26,27)(H,30,31)/t19?,22-/m1/s1	PQIBUBHQMPNGFL-AVKWCDSFSA-N	459338	US10759813, Example 15-73	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459338	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459338&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903454	441290600					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948912	CCCc1cc([nH]n1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C24H27N3O4/c1-2-6-19-14-21(27-26-19)23(29)25-20(15-22(28)24(30)31)13-16-9-11-18(12-10-16)17-7-4-3-5-8-17/h3-5,7-12,14,20,22,28H,2,6,13,15H2,1H3,(H,25,29)(H,26,27)(H,30,31)/t20?,22-/m1/s1	WCYQXWHGONQVOG-LWMIZPGFSA-N	459339	US10759813, Example 15-74	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459339	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459339&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903455	441290601					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948913	CCCCc1cc([nH]n1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C25H29N3O4/c1-2-3-9-20-15-22(28-27-20)24(30)26-21(16-23(29)25(31)32)14-17-10-12-19(13-11-17)18-7-5-4-6-8-18/h4-8,10-13,15,21,23,29H,2-3,9,14,16H2,1H3,(H,26,30)(H,27,28)(H,31,32)/t21?,23-/m1/s1	VZDPDDBTAKHRGS-JFGZAKSSSA-N	459340	US10759813, Example 15-75	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459340	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459340&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903456	441290602					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948914	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)-c1ccccc1)C(O)=O	InChI=1S/C27H25N3O4/c31-25(27(33)34)16-22(15-18-11-13-20(14-12-18)19-7-3-1-4-8-19)28-26(32)24-17-23(29-30-24)21-9-5-2-6-10-21/h1-14,17,22,25,31H,15-16H2,(H,28,32)(H,29,30)(H,33,34)/t22?,25-/m1/s1	ILZQVFHIMPFPPI-NRWPOFLRSA-N	459341	US10759813, Example 15-76	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459341	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459341&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903457	441290603					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948915	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(nn1CCC(O)=O)-c1ccccc1)C(O)=O	InChI=1S/C30H29N3O6/c34-27(30(38)39)18-24(17-20-11-13-22(14-12-20)21-7-3-1-4-8-21)31-29(37)26-19-25(23-9-5-2-6-10-23)32-33(26)16-15-28(35)36/h1-14,19,24,27,34H,15-18H2,(H,31,37)(H,35,36)(H,38,39)/t24-,27-/m1/s1	XMOVVDUJPOBLQS-SHQCIBLASA-N	459342	US10759813, Example 15-77	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459342	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459342&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969514	441290604					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948916	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(nn1CCC(O)=O)-c1ccccc1)C(O)=O	InChI=1S/C30H29N3O6/c34-27(30(38)39)18-24(17-20-11-13-22(14-12-20)21-7-3-1-4-8-21)31-29(37)26-19-25(23-9-5-2-6-10-23)32-33(26)16-15-28(35)36/h1-14,19,24,27,34H,15-18H2,(H,31,37)(H,35,36)(H,38,39)/t24-,27-/m1/s1	XMOVVDUJPOBLQS-SHQCIBLASA-N	459342	US10759813, Example 15-77	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459342	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459342&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969514	441290604					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948917	COc1ccccc1-c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C28H27N3O5/c1-36-26-10-6-5-9-22(26)23-17-24(31-30-23)27(33)29-21(16-25(32)28(34)35)15-18-11-13-20(14-12-18)19-7-3-2-4-8-19/h2-14,17,21,25,32H,15-16H2,1H3,(H,29,33)(H,30,31)(H,34,35)/t21-,25-/m1/s1	UVQRQXPFKFLXAJ-PXDATVDWSA-N	459343	US10759813, Example 15-79	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459343	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459343&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903458	441290605					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948918	COc1ccc(OC)c(c1)-c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C29H29N3O6/c1-37-22-12-13-27(38-2)23(16-22)24-17-25(32-31-24)28(34)30-21(15-26(33)29(35)36)14-18-8-10-20(11-9-18)19-6-4-3-5-7-19/h3-13,16-17,21,26,33H,14-15H2,1-2H3,(H,30,34)(H,31,32)(H,35,36)/t21-,26-/m1/s1	DRKIUMDDXKQCJO-QFQXNSOFSA-N	459344	US10759813, Example 15-80	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459344	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459344&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903459	441290606					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948919	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)-c1ccccc1C(F)(F)F)C(O)=O	InChI=1S/C28H24F3N3O4/c29-28(30,31)22-9-5-4-8-21(22)23-16-24(34-33-23)26(36)32-20(15-25(35)27(37)38)14-17-10-12-19(13-11-17)18-6-2-1-3-7-18/h1-13,16,20,25,35H,14-15H2,(H,32,36)(H,33,34)(H,37,38)/t20?,25-/m1/s1	ZHSQREQLHSTZAB-GBAXHLBXSA-N	459345	US10759813, Example 15-81	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459345	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459345&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903460	441290607					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948920	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)-c1ccc(F)cc1)C(O)=O	InChI=1S/C27H24FN3O4/c28-21-12-10-20(11-13-21)23-16-24(31-30-23)26(33)29-22(15-25(32)27(34)35)14-17-6-8-19(9-7-17)18-4-2-1-3-5-18/h1-13,16,22,25,32H,14-15H2,(H,29,33)(H,30,31)(H,34,35)/t22?,25-/m1/s1	NIESJJWHVIJFNQ-NRWPOFLRSA-N	459346	US10759813, Example 15-82	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459346	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459346&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903461	441290608					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948921	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)-c1ccc(Cl)cc1)C(O)=O	InChI=1S/C27H24ClN3O4/c28-21-12-10-20(11-13-21)23-16-24(31-30-23)26(33)29-22(15-25(32)27(34)35)14-17-6-8-19(9-7-17)18-4-2-1-3-5-18/h1-13,16,22,25,32H,14-15H2,(H,29,33)(H,30,31)(H,34,35)/t22?,25-/m1/s1	JFFXFTKPDCLOFP-NRWPOFLRSA-N	459347	US10759813, Example 15-83	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459347	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459347&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903434	441290609					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948922	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)-c1ccccc1Cl)C(O)=O	InChI=1S/C27H24ClN3O4/c28-22-9-5-4-8-21(22)23-16-24(31-30-23)26(33)29-20(15-25(32)27(34)35)14-17-10-12-19(13-11-17)18-6-2-1-3-7-18/h1-13,16,20,25,32H,14-15H2,(H,29,33)(H,30,31)(H,34,35)/t20-,25-/m1/s1	JDYIJBGFSSDJKO-CJFMBICVSA-N	459348	US10759813, Example 15-84	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459348	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459348&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903462	441290610					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948923	COc1ccc(F)cc1-c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C28H26FN3O5/c1-37-26-12-11-20(29)14-22(26)23-16-24(32-31-23)27(34)30-21(15-25(33)28(35)36)13-17-7-9-19(10-8-17)18-5-3-2-4-6-18/h2-12,14,16,21,25,33H,13,15H2,1H3,(H,30,34)(H,31,32)(H,35,36)/t21-,25-/m1/s1	FRSRCKGCOSKKFG-PXDATVDWSA-N	459349	US10759813, Example 15-86	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459349	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459349&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903463	441290611					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948924	Cc1ccc(s1)-c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C26H25N3O4S/c1-16-7-12-24(34-16)21-15-22(29-28-21)25(31)27-20(14-23(30)26(32)33)13-17-8-10-19(11-9-17)18-5-3-2-4-6-18/h2-12,15,20,23,30H,13-14H2,1H3,(H,27,31)(H,28,29)(H,32,33)/t20-,23-/m1/s1	UHIJAIOGQNXRGM-NFBKMPQASA-N	459350	US10759813, Example 15-89	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459350	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459350&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903464	441290612					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948925	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)-c1ccc(Cl)s1)C(O)=O	InChI=1S/C25H22ClN3O4S/c26-23-11-10-22(34-23)19-14-20(29-28-19)24(31)27-18(13-21(30)25(32)33)12-15-6-8-17(9-7-15)16-4-2-1-3-5-16/h1-11,14,18,21,30H,12-13H2,(H,27,31)(H,28,29)(H,32,33)/t18-,21-/m1/s1	GJFWGZZLRJOTEY-WIYYLYMNSA-N	459351	US10759813, Example 15-90	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459351	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459351&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903465	441290613					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948926	CCC(=O)Nc1cc([nH]n1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C24H26N4O5/c1-2-22(30)26-21-14-19(27-28-21)23(31)25-18(13-20(29)24(32)33)12-15-8-10-17(11-9-15)16-6-4-3-5-7-16/h3-11,14,18,20,29H,2,12-13H2,1H3,(H,25,31)(H,32,33)(H2,26,27,28,30)/t18?,20-/m1/s1	OYRMZGBAOXLKTL-ROPPNANJSA-N	459352	US10759813, Example 15-91	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459352	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459352&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903466	441290614					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948927	CCCCC(=O)Nc1cc([nH]n1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C26H30N4O5/c1-2-3-9-24(32)28-23-16-21(29-30-23)25(33)27-20(15-22(31)26(34)35)14-17-10-12-19(13-11-17)18-7-5-4-6-8-18/h4-8,10-13,16,20,22,31H,2-3,9,14-15H2,1H3,(H,27,33)(H,34,35)(H2,28,29,30,32)/t20?,22-/m1/s1	HELZAXNVPOPVQD-LWMIZPGFSA-N	459353	US10759813, Example 15-92	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459353	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459353&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903467	441290615					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948928	CCOC(=O)Nc1cc([nH]n1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C24H26N4O6/c1-2-34-24(33)26-21-14-19(27-28-21)22(30)25-18(13-20(29)23(31)32)12-15-8-10-17(11-9-15)16-6-4-3-5-7-16/h3-11,14,18,20,29H,2,12-13H2,1H3,(H,25,30)(H,31,32)(H2,26,27,28,33)/t18?,20-/m1/s1	PVIOPPWWFDOHQQ-ROPPNANJSA-N	459354	US10759813, Example 15-93	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459354	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459354&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903468	441290616					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948929	COCC(=O)Nc1cc([nH]n1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C24H26N4O6/c1-34-14-22(30)26-21-13-19(27-28-21)23(31)25-18(12-20(29)24(32)33)11-15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-10,13,18,20,29H,11-12,14H2,1H3,(H,25,31)(H,32,33)(H2,26,27,28,30)/t18?,20-/m1/s1	AJCUOXRIQFVVER-ROPPNANJSA-N	459355	US10759813, Example 15-94	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459355	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459355&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903469	441290617					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948930	COc1ccccc1C(=O)Nc1cc([nH]n1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C29H28N4O6/c1-39-25-10-6-5-9-22(25)27(35)31-26-17-23(32-33-26)28(36)30-21(16-24(34)29(37)38)15-18-11-13-20(14-12-18)19-7-3-2-4-8-19/h2-14,17,21,24,34H,15-16H2,1H3,(H,30,36)(H,37,38)(H2,31,32,33,35)/t21?,24-/m1/s1	XCQXWKMCIDKMQO-MQNHUJCZSA-N	459356	US10759813, Example 15-95	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459356	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459356&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903470	441290618					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948931	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(NC(=O)c2ccccc2Cl)n[nH]1)C(O)=O	InChI=1S/C28H25ClN4O5/c29-22-9-5-4-8-21(22)26(35)31-25-16-23(32-33-25)27(36)30-20(15-24(34)28(37)38)14-17-10-12-19(13-11-17)18-6-2-1-3-7-18/h1-13,16,20,24,34H,14-15H2,(H,30,36)(H,37,38)(H2,31,32,33,35)/t20-,24-/m1/s1	LRBVTAGEJRRNDG-HYBUGGRVSA-N	459357	US10759813, Example 15-96	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459357	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459357&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903471	441290619					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948932	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(NC(=O)c2ccccn2)n[nH]1)C(O)=O	InChI=1S/C27H25N5O5/c33-23(27(36)37)15-20(14-17-9-11-19(12-10-17)18-6-2-1-3-7-18)29-26(35)22-16-24(32-31-22)30-25(34)21-8-4-5-13-28-21/h1-13,16,20,23,33H,14-15H2,(H,29,35)(H,36,37)(H2,30,31,32,34)/t20?,23-/m1/s1	YSNJBGDKQSDKCI-GWQXNCQPSA-N	459358	US10759813, Example 15-100	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459358	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459358&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903472	441290620					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948933	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)-c1ccccn1)C(O)=O	InChI=1S/C26H24N4O4/c31-24(26(33)34)15-20(14-17-9-11-19(12-10-17)18-6-2-1-3-7-18)28-25(32)23-16-22(29-30-23)21-8-4-5-13-27-21/h1-13,16,20,24,31H,14-15H2,(H,28,32)(H,29,30)(H,33,34)/t20-,24-/m1/s1	MBABQOAIOGVKSD-HYBUGGRVSA-N	459359	US10759813, Example 15-101	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459359	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459359&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903473	441290621					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948934	Nc1cc([nH]n1)C(=O)NC(C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C21H22N4O4/c22-19-12-17(24-25-19)20(27)23-16(11-18(26)21(28)29)10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9,12,16,18,26H,10-11H2,(H,23,27)(H,28,29)(H3,22,24,25)/t16?,18-/m1/s1	GGTRFQLYTQJFSB-UHUGOGIASA-N	459360	US10759813, Example 15-102	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459360	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459360&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903474	441290622					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948935	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc(n[nH]1)-c1cnccn1)C(O)=O	InChI=1S/C25H23N5O4/c31-23(25(33)34)13-19(12-16-6-8-18(9-7-16)17-4-2-1-3-5-17)28-24(32)21-14-20(29-30-21)22-15-26-10-11-27-22/h1-11,14-15,19,23,31H,12-13H2,(H,28,32)(H,29,30)(H,33,34)/t19-,23-/m1/s1	PIPIRKUSVIBCNP-AUSIDOKSSA-N	459361	US10759813, Example 15-106	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459361	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459361&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903475	441290623					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948936	CC(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(N)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C23H24N4O4/c1-14(28)19-13-20(27-26-19)23(31)25-18(12-21(29)22(24)30)11-15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-10,13,18,21,29H,11-12H2,1H3,(H2,24,30)(H,25,31)(H,26,27)/t18-,21-/m1/s1	HODCZVTVCLSEGB-WIYYLYMNSA-N	459362	US10759813, Example 15-108	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459362	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459362&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903476	441290624							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948937	C[C@H](O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C23H25N3O5/c1-14(27)19-13-20(26-25-19)22(29)24-18(12-21(28)23(30)31)11-15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-10,13-14,18,21,27-28H,11-12H2,1H3,(H,24,29)(H,25,26)(H,30,31)/t14-,18+,21+/m0/s1	ZIRSBBMVOMYMOR-FIKMYACPSA-N	459363	US10759813, Example 15-109	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459363	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459363&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903477	441290625					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948938	C[C@@H](O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C23H25N3O5/c1-14(27)19-13-20(26-25-19)22(29)24-18(12-21(28)23(30)31)11-15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-10,13-14,18,21,27-28H,11-12H2,1H3,(H,24,29)(H,25,26)(H,30,31)/t14-,18-,21-/m1/s1	ZIRSBBMVOMYMOR-CFCCAZDESA-N	459364	US10759813, Example 15-110	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459364	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459364&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903478	441290626					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948939	C\C(=N/O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C23H24N4O5/c1-14(27-32)19-13-20(26-25-19)22(29)24-18(12-21(28)23(30)31)11-15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-10,13,18,21,28,32H,11-12H2,1H3,(H,24,29)(H,25,26)(H,30,31)/b27-14+/t18-,21-/m1/s1	KTYCOYVAYHIQPI-QOQZGBSDSA-N	459365	US10759813, Example 15-111	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459365	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459365&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903479	441290627					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948940	CCCCc1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1ccccc1	InChI=1S/C25H29N3O4/c1-2-3-9-20-15-22(28-27-20)24(30)26-21(16-23(29)25(31)32)14-17-10-12-19(13-11-17)18-7-5-4-6-8-18/h4-8,10-13,15,21,23,29H,2-3,9,14,16H2,1H3,(H,26,30)(H,27,28)(H,31,32)/t21-,23-/m1/s1	VZDPDDBTAKHRGS-FYYLOGMGSA-N	459366	US10759813, Example 15-112	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459366&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903480	441290628					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948941	O[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cn[nH]c1)C(O)=O	InChI=1S/C21H21N3O4/c25-19(21(27)28)11-18(24-20(26)17-12-22-23-13-17)10-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-9,12-13,18-19,25H,10-11H2,(H,22,23)(H,24,26)(H,27,28)/t18?,19-/m1/s1	YOYBDCLVQLCTQK-MUMRKEEXSA-N	459367	US10759813, Example 15-113	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459367&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903481	441290629					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948942	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc2-c3ccccc3OCCn2n1)C(O)=O	InChI=1S/C29H27N3O5/c33-26(29(35)36)17-22(16-19-10-12-21(13-11-19)20-6-2-1-3-7-20)30-28(34)24-18-25-23-8-4-5-9-27(23)37-15-14-32(25)31-24/h1-13,18,22,26,33H,14-17H2,(H,30,34)(H,35,36)/t22-,26-/m1/s1	RRMZMAKPAVHIJT-ATIYNZHBSA-N	459368	US10759813, Example 16-1	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459368&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969897	441290630					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948943	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc-2nn1CCOc1ccccc-21)C(O)=O	InChI=1S/C29H27N3O5/c33-26(29(35)36)17-22(16-19-10-12-21(13-11-19)20-6-2-1-3-7-20)30-28(34)25-18-24-23-8-4-5-9-27(23)37-15-14-32(25)31-24/h1-13,18,22,26,33H,14-17H2,(H,30,34)(H,35,36)/t22-,26-/m1/s1	AHCIUUDOIOYWKL-ATIYNZHBSA-N	459369	US10759813, Example 16-2	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459369&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67976920	441290631					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948944	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc2-c3ccccc3OCCCn2n1)C(O)=O	InChI=1S/C30H29N3O5/c34-27(30(36)37)18-23(17-20-11-13-22(14-12-20)21-7-2-1-3-8-21)31-29(35)25-19-26-24-9-4-5-10-28(24)38-16-6-15-33(26)32-25/h1-5,7-14,19,23,27,34H,6,15-18H2,(H,31,35)(H,36,37)/t23-,27-/m1/s1	IEZYIYGWRCANCX-YIXXDRMTSA-N	459370	US10759813, Example 16-3	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459370&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961918	441290632					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948945	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc2-c3ccccc3OC[C@@H](O)Cn2n1)C(O)=O	InChI=1S/C30H29N3O6/c34-23-17-33-26(24-8-4-5-9-28(24)39-18-23)16-25(32-33)29(36)31-22(15-27(35)30(37)38)14-19-10-12-21(13-11-19)20-6-2-1-3-7-20/h1-13,16,22-23,27,34-35H,14-15,17-18H2,(H,31,36)(H,37,38)/t22-,23+,27-/m1/s1	LDRVLWYTBSQFOW-QSEAXJEQSA-N	459371	US10759813, Example 16-4	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459371&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969545	441290633					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948946	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc2-c3ccccc3OC[C@H](O)Cn2n1)C(O)=O	InChI=1S/C30H29N3O6/c34-23-17-33-26(24-8-4-5-9-28(24)39-18-23)16-25(32-33)29(36)31-22(15-27(35)30(37)38)14-19-10-12-21(13-11-19)20-6-2-1-3-7-20/h1-13,16,22-23,27,34-35H,14-15,17-18H2,(H,31,36)(H,37,38)/t22-,23-,27-/m1/s1	LDRVLWYTBSQFOW-AZSVPQILSA-N	459372	US10759813, Example 16-5	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459372&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969470	441290634					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948947	O[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cc2-c3ccccc3OCn2n1)C(O)=O	InChI=1S/C28H25N3O5/c32-25(28(34)35)15-21(14-18-10-12-20(13-11-18)19-6-2-1-3-7-19)29-27(33)23-16-24-22-8-4-5-9-26(22)36-17-31(24)30-23/h1-13,16,21,25,32H,14-15,17H2,(H,29,33)(H,34,35)/t21-,25-/m1/s1	PABTUHVQVPNGKD-PXDATVDWSA-N	459373	US10759813, Example 16-6	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459373&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969904	441290635					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948948	CCOC(=O)[C@H](O)C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cn(O)nn1	InChI=1S/C22H23ClN4O5/c1-2-32-22(30)20(28)12-18(24-21(29)19-13-27(31)26-25-19)10-14-6-8-15(9-7-14)16-4-3-5-17(23)11-16/h3-9,11,13,18,20,28,31H,2,10,12H2,1H3,(H,24,29)/t18-,20-/m1/s1	DVHWLFDNWHQEFR-UYAOXDASSA-N	459374	US10759813, Example 17-A	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459374&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			57378091	441290636							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948949	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1c[nH]nn1)C(O)=O	InChI=1S/C20H19ClN4O4/c21-15-3-1-2-14(9-15)13-6-4-12(5-7-13)8-16(10-18(26)20(28)29)23-19(27)17-11-22-25-24-17/h1-7,9,11,16,18,26H,8,10H2,(H,23,27)(H,28,29)(H,22,24,25)/t16-,18-/m1/s1	FKNUKBXPIGQPIK-SJLPKXTDSA-N	459375	US10759813, Example 18-2	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459375&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969488	441290637					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948950	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1ccc2nnn(O)c2c1)C(O)=O	InChI=1S/C24H21ClN4O5/c25-18-3-1-2-16(11-18)15-6-4-14(5-7-15)10-19(13-22(30)24(32)33)26-23(31)17-8-9-20-21(12-17)29(34)28-27-20/h1-9,11-12,19,22,30,34H,10,13H2,(H,26,31)(H,32,33)/t19-,22-/m1/s1	VQKKINGSQSWSBG-DENIHFKCSA-N	459376	US10759813, Example 18-3	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459376&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67970017	441290638					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948951	CC(=O)c1cc(on1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1cccc(Cl)c1	InChI=1S/C23H21ClN2O6/c1-13(27)19-12-21(32-26-19)22(29)25-18(11-20(28)23(30)31)9-14-5-7-15(8-6-14)16-3-2-4-17(24)10-16/h2-8,10,12,18,20,28H,9,11H2,1H3,(H,25,29)(H,30,31)/t18-,20-/m1/s1	IYHRJVNLOAHLJS-UYAOXDASSA-N	459377	US10759813, Example 18-7	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459377&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961832	441290639					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948952	COc1cc(on1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1cccc(Cl)c1	InChI=1S/C22H21ClN2O6/c1-30-20-12-19(31-25-20)21(27)24-17(11-18(26)22(28)29)9-13-5-7-14(8-6-13)15-3-2-4-16(23)10-15/h2-8,10,12,17-18,26H,9,11H2,1H3,(H,24,27)(H,28,29)/t17-,18-/m1/s1	LWJVOGQURBNBBN-QZTJIDSGSA-N	459378	US10759813, Example 18-8	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459378&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969790	441290640					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948953	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc(Cl)no1)C(O)=O	InChI=1S/C21H18Cl2N2O5/c22-15-3-1-2-14(9-15)13-6-4-12(5-7-13)8-16(10-17(26)21(28)29)24-20(27)18-11-19(23)25-30-18/h1-7,9,11,16-17,26H,8,10H2,(H,24,27)(H,28,29)/t16-,17-/m1/s1	BVWWJCHELFVOBY-IAGOWNOFSA-N	459379	US10759813, Example 18-9	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459379&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961818	441290641					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948954	CC(C)c1cc(on1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1cccc(Cl)c1	InChI=1S/C24H25ClN2O5/c1-14(2)20-13-22(32-27-20)23(29)26-19(12-21(28)24(30)31)10-15-6-8-16(9-7-15)17-4-3-5-18(25)11-17/h3-9,11,13-14,19,21,28H,10,12H2,1-2H3,(H,26,29)(H,30,31)/t19-,21-/m1/s1	VDDHXNGORWWWDH-TZIWHRDSSA-N	459380	US10759813, Example 18-10	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459380&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67970033	441290642					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948955	CCCc1cc(on1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1cccc(Cl)c1	InChI=1S/C24H25ClN2O5/c1-2-4-19-14-22(32-27-19)23(29)26-20(13-21(28)24(30)31)11-15-7-9-16(10-8-15)17-5-3-6-18(25)12-17/h3,5-10,12,14,20-21,28H,2,4,11,13H2,1H3,(H,26,29)(H,30,31)/t20-,21-/m1/s1	ZRVUDXFCAXCCSV-NHCUHLMSSA-N	459381	US10759813, Example 18-11	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459381&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969894	441290643					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948956	CC(C)Cc1cc(on1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1cccc(Cl)c1	InChI=1S/C25H27ClN2O5/c1-15(2)10-21-14-23(33-28-21)24(30)27-20(13-22(29)25(31)32)11-16-6-8-17(9-7-16)18-4-3-5-19(26)12-18/h3-9,12,14-15,20,22,29H,10-11,13H2,1-2H3,(H,27,30)(H,31,32)/t20-,22-/m1/s1	XBRLDISVEXERED-IFMALSPDSA-N	459382	US10759813, Example 18-12	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459382	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459382&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969458	441290644					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948957	CC(C)(O)c1cc(on1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1cccc(Cl)c1	InChI=1S/C24H25ClN2O6/c1-24(2,32)21-13-20(33-27-21)22(29)26-18(12-19(28)23(30)31)10-14-6-8-15(9-7-14)16-4-3-5-17(25)11-16/h3-9,11,13,18-19,28,32H,10,12H2,1-2H3,(H,26,29)(H,30,31)/t18-,19-/m1/s1	RLEOYTHVZZXTQI-RTBURBONSA-N	459383	US10759813, Example 18-13	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459383	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459383&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969835	441290645					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948958	CC(C)(C)c1cc(on1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1cccc(Cl)c1	InChI=1S/C25H27ClN2O5/c1-25(2,3)22-14-21(33-28-22)23(30)27-19(13-20(29)24(31)32)11-15-7-9-16(10-8-15)17-5-4-6-18(26)12-17/h4-10,12,14,19-20,29H,11,13H2,1-3H3,(H,27,30)(H,31,32)/t19-,20-/m1/s1	QMNFKISJULWWKD-WOJBJXKFSA-N	459384	US10759813, Example 18-14	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459384	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459384&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961914	441290646					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948959	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc(on1)-c1ccccc1Cl)C(O)=O	InChI=1S/C27H22Cl2N2O5/c28-19-5-3-4-18(13-19)17-10-8-16(9-11-17)12-20(14-24(32)27(34)35)30-26(33)23-15-25(36-31-23)21-6-1-2-7-22(21)29/h1-11,13,15,20,24,32H,12,14H2,(H,30,33)(H,34,35)/t20-,24-/m1/s1	BSUFBCUNFHOMLU-HYBUGGRVSA-N	459385	US10759813, Example 18-15	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459385	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459385&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961921	441290647					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948960	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc(on1)-c1ccccc1O)C(O)=O	InChI=1S/C27H23ClN2O6/c28-19-5-3-4-18(13-19)17-10-8-16(9-11-17)12-20(14-24(32)27(34)35)29-26(33)22-15-25(36-30-22)21-6-1-2-7-23(21)31/h1-11,13,15,20,24,31-32H,12,14H2,(H,29,33)(H,34,35)/t20-,24-/m1/s1	HPRLLLCTWMWMRZ-HYBUGGRVSA-N	459386	US10759813, Example 18-16	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459386	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459386&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			136480945	441290648					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948961	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc(n[nH]1)-c1ccccc1O)C(O)=O	InChI=1S/C27H24ClN3O5/c28-19-5-3-4-18(13-19)17-10-8-16(9-11-17)12-20(14-25(33)27(35)36)29-26(34)23-15-22(30-31-23)21-6-1-2-7-24(21)32/h1-11,13,15,20,25,32-33H,12,14H2,(H,29,34)(H,30,31)(H,35,36)/t20-,25-/m1/s1	ZXVLQDXAWPTVGK-CJFMBICVSA-N	459387	US10759813, Example 18-17	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459387	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459387&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903482	441290649					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948962	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc(n[nH]1)-c1cnccn1)C(O)=O	InChI=1S/C25H22ClN5O4/c26-18-3-1-2-17(11-18)16-6-4-15(5-7-16)10-19(12-23(32)25(34)35)29-24(33)21-13-20(30-31-21)22-14-27-8-9-28-22/h1-9,11,13-14,19,23,32H,10,12H2,(H,29,33)(H,30,31)(H,34,35)/t19-,23-/m1/s1	LFAUDWLNOCSZCU-AUSIDOKSSA-N	459388	US10759813, Example 18-19	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459388	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459388&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903483	441290650					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948963	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc(n[nH]1)-c1ccccn1)C(O)=O	InChI=1S/C26H23ClN4O4/c27-19-5-3-4-18(13-19)17-9-7-16(8-10-17)12-20(14-24(32)26(34)35)29-25(33)23-15-22(30-31-23)21-6-1-2-11-28-21/h1-11,13,15,20,24,32H,12,14H2,(H,29,33)(H,30,31)(H,34,35)/t20-,24-/m1/s1	GEUPBDDRHRHDOU-HYBUGGRVSA-N	459389	US10759813, Example 18-23	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459389	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459389&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903484	441290651					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948964	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc(NC(=O)c2ccccc2Cl)n[nH]1)C(O)=O	InChI=1S/C28H24Cl2N4O5/c29-19-5-3-4-18(13-19)17-10-8-16(9-11-17)12-20(14-24(35)28(38)39)31-27(37)23-15-25(34-33-23)32-26(36)21-6-1-2-7-22(21)30/h1-11,13,15,20,24,35H,12,14H2,(H,31,37)(H,38,39)(H2,32,33,34,36)/t20-,24-/m1/s1	BKDZREXHVZTNAX-HYBUGGRVSA-N	459390	US10759813, Example 18-27	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459390	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459390&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903485	441290652					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948965	COc1ccccc1C(=O)Nc1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1cccc(Cl)c1	InChI=1S/C29H27ClN4O6/c1-40-25-8-3-2-7-22(25)27(36)32-26-16-23(33-34-26)28(37)31-21(15-24(35)29(38)39)13-17-9-11-18(12-10-17)19-5-4-6-20(30)14-19/h2-12,14,16,21,24,35H,13,15H2,1H3,(H,31,37)(H,38,39)(H2,32,33,34,36)/t21-,24-/m1/s1	VZLSYQRGUFRGPC-ZJSXRUAMSA-N	459391	US10759813, Example 18-31	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459391	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459391&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903486	441290653					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948966	CC(O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1cccc(Cl)c1	InChI=1S/C23H24ClN3O5/c1-13(28)19-12-20(27-26-19)22(30)25-18(11-21(29)23(31)32)9-14-5-7-15(8-6-14)16-3-2-4-17(24)10-16/h2-8,10,12-13,18,21,28-29H,9,11H2,1H3,(H,25,30)(H,26,27)(H,31,32)/t13?,18-,21-/m1/s1	JCLXVERIGSWXNF-WGVFCVCTSA-N	459392	US10759813, Example 18-32	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459392	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459392&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961909	441290654					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948967	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc([nH]n1)-c1cccnc1)C(O)=O	InChI=1S/C26H23ClN4O4/c27-20-5-1-3-18(12-20)17-8-6-16(7-9-17)11-21(13-24(32)26(34)35)29-25(33)23-14-22(30-31-23)19-4-2-10-28-15-19/h1-10,12,14-15,21,24,32H,11,13H2,(H,29,33)(H,30,31)(H,34,35)/t21-,24-/m1/s1	YTQGFBCIOIZWQZ-ZJSXRUAMSA-N	459393	US10759813, Example 18-34	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459393	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459393&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903487	441290655					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948968	Cn1nc(cc1O)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1cccc(Cl)c1	InChI=1S/C22H22ClN3O5/c1-26-20(28)12-18(25-26)21(29)24-17(11-19(27)22(30)31)9-13-5-7-14(8-6-13)15-3-2-4-16(23)10-15/h2-8,10,12,17,19,27-28H,9,11H2,1H3,(H,24,29)(H,30,31)/t17-,19-/m1/s1	NFOKEAJFCWLRQF-IEBWSBKVSA-N	459394	US10759813, Example 18-35	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459394	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459394&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67970057	441290656					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948969	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc(O)n(n1)-c1ccccn1)C(O)=O	InChI=1S/C26H23ClN4O5/c27-19-5-3-4-18(13-19)17-9-7-16(8-10-17)12-20(14-22(32)26(35)36)29-25(34)21-15-24(33)31(30-21)23-6-1-2-11-28-23/h1-11,13,15,20,22,32-33H,12,14H2,(H,29,34)(H,35,36)/t20-,22-/m1/s1	XAUFQBAYFCIXSZ-IFMALSPDSA-N	459395	US10759813, Example 18-37	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459395	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459395&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969837	441290657					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948970	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc(O)n(n1)-c1ccccc1F)C(O)=O	InChI=1S/C27H23ClFN3O5/c28-19-5-3-4-18(13-19)17-10-8-16(9-11-17)12-20(14-24(33)27(36)37)30-26(35)22-15-25(34)32(31-22)23-7-2-1-6-21(23)29/h1-11,13,15,20,24,33-34H,12,14H2,(H,30,35)(H,36,37)/t20-,24-/m1/s1	ACXSZORWHXBHHH-HYBUGGRVSA-N	459396	US10759813, Example 18-38	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459396	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459396&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969747	441290658					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948971	O[C@H](C[C@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc(O)n(n1)-c1cccc(Cl)c1)C(O)=O	InChI=1S/C27H23Cl2N3O5/c28-19-4-1-3-18(12-19)17-9-7-16(8-10-17)11-21(14-24(33)27(36)37)30-26(35)23-15-25(34)32(31-23)22-6-2-5-20(29)13-22/h1-10,12-13,15,21,24,33-34H,11,14H2,(H,30,35)(H,36,37)/t21-,24+/m0/s1	LFTCTGTWRSXWIA-XUZZJYLKSA-N	459397	US10759813, Example 18-39	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459397	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459397&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969876	441290659					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948972	CCOc1cc(n[nH]1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1cccc(Cl)c1	InChI=1S/C23H24ClN3O5/c1-2-32-21-13-19(26-27-21)22(29)25-18(12-20(28)23(30)31)10-14-6-8-15(9-7-14)16-4-3-5-17(24)11-16/h3-9,11,13,18,20,28H,2,10,12H2,1H3,(H,25,29)(H,26,27)(H,30,31)/t18-,20-/m1/s1	WDUVZEXDSYXLNJ-UYAOXDASSA-N	459398	US10759813, Example 18-40	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459398	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459398&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969986	441290660					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948973	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc(=O)n([nH]1)-c1ccccc1)C(O)=O	InChI=1S/C27H24ClN3O5/c28-20-6-4-5-19(14-20)18-11-9-17(10-12-18)13-21(15-24(32)27(35)36)29-26(34)23-16-25(33)31(30-23)22-7-2-1-3-8-22/h1-12,14,16,21,24,30,32H,13,15H2,(H,29,34)(H,35,36)/t21-,24-/m1/s1	JMMTXWAWXYXATG-ZJSXRUAMSA-N	459399	US10759813, Example 18-41	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459399	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459399&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969559	441290661					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948974	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1nn(-c2cccc(Cl)c2)c(=O)[nH]1)C(O)=O	InChI=1S/C26H22Cl2N4O5/c27-18-4-1-3-17(12-18)16-9-7-15(8-10-16)11-20(14-22(33)25(35)36)29-24(34)23-30-26(37)32(31-23)21-6-2-5-19(28)13-21/h1-10,12-13,20,22,33H,11,14H2,(H,29,34)(H,35,36)(H,30,31,37)/t20-,22-/m1/s1	NRAXENQFFXIXPY-IFMALSPDSA-N	459400	US10759813, Example 18-42	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459400	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459400&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			136480937	441290662					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948975	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1nn(-c2ccccc2Cl)c(=O)[nH]1)C(O)=O	InChI=1S/C26H22Cl2N4O5/c27-18-5-3-4-17(13-18)16-10-8-15(9-11-16)12-19(14-22(33)25(35)36)29-24(34)23-30-26(37)32(31-23)21-7-2-1-6-20(21)28/h1-11,13,19,22,33H,12,14H2,(H,29,34)(H,35,36)(H,30,31,37)/t19-,22-/m1/s1	CXRAQWJCWYZWBB-DENIHFKCSA-N	459401	US10759813, Example 18-43	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459401	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459401&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			136480946	441290663					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948976	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1nn(-c2ccc(F)cc2)c(=O)[nH]1)C(O)=O	InChI=1S/C26H22ClFN4O5/c27-18-3-1-2-17(13-18)16-6-4-15(5-7-16)12-20(14-22(33)25(35)36)29-24(34)23-30-26(37)32(31-23)21-10-8-19(28)9-11-21/h1-11,13,20,22,33H,12,14H2,(H,29,34)(H,35,36)(H,30,31,37)/t20-,22-/m1/s1	DIZCNAXJTNCZDP-IFMALSPDSA-N	459402	US10759813, Example 18-44	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459402	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459402&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			136480947	441290664					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948977	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1nnc([nH]1)C(F)(F)F)C(O)=O	InChI=1S/C21H18ClF3N4O4/c22-14-3-1-2-13(9-14)12-6-4-11(5-7-12)8-15(10-16(30)19(32)33)26-18(31)17-27-20(29-28-17)21(23,24)25/h1-7,9,15-16,30H,8,10H2,(H,26,31)(H,32,33)(H,27,28,29)/t15-,16-/m1/s1	KPKHMCWUWITJJJ-HZPDHXFCSA-N	459403	US10759813, Example 18-45	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459403	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459403&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969407	441290665					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948978	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1n[nH]c(Cl)n1)C(O)=O	InChI=1S/C20H18Cl2N4O4/c21-14-3-1-2-13(9-14)12-6-4-11(5-7-12)8-15(10-16(27)19(29)30)23-18(28)17-24-20(22)26-25-17/h1-7,9,15-16,27H,8,10H2,(H,23,28)(H,29,30)(H,24,25,26)/t15-,16-/m1/s1	TUZJNGBVYYYPPM-HZPDHXFCSA-N	459404	US10759813, Example 18-46	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459404	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459404&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969465	441290666					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948979	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1nn(-c2ccccc2)c(=O)[nH]1)C(O)=O	InChI=1S/C26H23ClN4O5/c27-19-6-4-5-18(14-19)17-11-9-16(10-12-17)13-20(15-22(32)25(34)35)28-24(33)23-29-26(36)31(30-23)21-7-2-1-3-8-21/h1-12,14,20,22,32H,13,15H2,(H,28,33)(H,34,35)(H,29,30,36)/t20-,22-/m1/s1	ANRURSWBKCDRQX-IFMALSPDSA-N	459405	US10759813, Example 18-47	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459405	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459405&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			136344442	441290667					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948980	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1ccc(=O)n(Cc2ccccc2)n1)C(O)=O	InChI=1S/C29H26ClN3O5/c30-23-8-4-7-22(16-23)21-11-9-19(10-12-21)15-24(17-26(34)29(37)38)31-28(36)25-13-14-27(35)33(32-25)18-20-5-2-1-3-6-20/h1-14,16,24,26,34H,15,17-18H2,(H,31,36)(H,37,38)/t24-,26-/m1/s1	DNTKHUXJTDLRCZ-AOYPEHQESA-N	459406	US10759813, Example 18-48	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459406	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459406&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67970114	441290668					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948981	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1ccc(=O)n(n1)-c1ccccc1)C(O)=O	InChI=1S/C28H24ClN3O5/c29-21-6-4-5-20(16-21)19-11-9-18(10-12-19)15-22(17-25(33)28(36)37)30-27(35)24-13-14-26(34)32(31-24)23-7-2-1-3-8-23/h1-14,16,22,25,33H,15,17H2,(H,30,35)(H,36,37)/t22-,25-/m1/s1	OZVPOXSMDWDDPN-RCZVLFRGSA-N	459407	US10759813, Example 18-49	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459407	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459407&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67975221	441290669					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948982	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1ccc(O)nn1)C(O)=O	InChI=1S/C22H20ClN3O5/c23-16-3-1-2-15(11-16)14-6-4-13(5-7-14)10-17(12-19(27)22(30)31)24-21(29)18-8-9-20(28)26-25-18/h1-9,11,17,19,27H,10,12H2,(H,24,29)(H,26,28)(H,30,31)/t17-,19-/m1/s1	SOSDALHHUDBXIO-IEBWSBKVSA-N	459408	US10759813, Example 18-50	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459408	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459408&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969554	441290670					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948983	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1Cl)NC(=O)c1cn(O)nn1)C(O)=O	InChI=1S/C20H18Cl2N4O5/c21-13-5-6-16(22)15(8-13)12-3-1-11(2-4-12)7-14(9-18(27)20(29)30)23-19(28)17-10-26(31)25-24-17/h1-6,8,10,14,18,27,31H,7,9H2,(H,23,28)(H,29,30)/t14-,18-/m1/s1	OBKLDTLYQYJJQM-RDTXWAMCSA-N	459409	US10759813, Example 19-1	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459409	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459409&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969740	441290671					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948984	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cn(O)nn1)C(O)=O	InChI=1S/C20H18ClFN4O5/c21-13-5-6-16(22)15(8-13)12-3-1-11(2-4-12)7-14(9-18(27)20(29)30)23-19(28)17-10-26(31)25-24-17/h1-6,8,10,14,18,27,31H,7,9H2,(H,23,28)(H,29,30)/t14-,18-/m1/s1	WEHBLFHSQATLGT-RDTXWAMCSA-N	459410	US10759813, Example 19-6	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459410	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459410&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969390	441290672					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948985	Cc1ccc(Cl)cc1-c1ccc(C[C@H](C[C@@H](O)C(O)=O)NC(=O)c2cn(O)nn2)cc1	InChI=1S/C21H21ClN4O5/c1-12-2-7-15(22)9-17(12)14-5-3-13(4-6-14)8-16(10-19(27)21(29)30)23-20(28)18-11-26(31)25-24-18/h2-7,9,11,16,19,27,31H,8,10H2,1H3,(H,23,28)(H,29,30)/t16-,19-/m1/s1	UJTRSZCGCKEAMZ-VQIMIIECSA-N	459411	US10759813, Example 19-12	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459411	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459411&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969933	441290673					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948986	COc1ccccc1-c1ccc(C[C@H](C[C@@H](O)C(O)=O)NC(=O)c2cn(O)nn2)cc1	InChI=1S/C21H22N4O6/c1-31-19-5-3-2-4-16(19)14-8-6-13(7-9-14)10-15(11-18(26)21(28)29)22-20(27)17-12-25(30)24-23-17/h2-9,12,15,18,26,30H,10-11H2,1H3,(H,22,27)(H,28,29)/t15-,18-/m1/s1	QKKATEWVRNNXDK-CRAIPNDOSA-N	459412	US10759813, Example 19-17	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459412	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459412&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969959	441290674					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948987	CC(=O)OCOn1nncc1C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C23H22ClFN4O7/c1-13(30)35-12-36-29-20(11-26-28-29)22(32)27-17(10-21(31)23(33)34)8-14-2-4-15(5-3-14)18-9-16(24)6-7-19(18)25/h2-7,9,11,17,21,31H,8,10,12H2,1H3,(H,27,32)(H,33,34)/t17-,21-/m1/s1	GBCGQWCQQDTTDW-DYESRHJHSA-N	459413	US10759813, Example 19-18	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459413	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459413&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961997	441290675					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948988	COc1cc(on1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C22H20ClFN2O6/c1-31-20-11-19(32-26-20)21(28)25-15(10-18(27)22(29)30)8-12-2-4-13(5-3-12)16-9-14(23)6-7-17(16)24/h2-7,9,11,15,18,27H,8,10H2,1H3,(H,25,28)(H,29,30)/t15-,18-/m1/s1	GZFJPNHTZHIBMZ-CRAIPNDOSA-N	459414	US10759813, Example 19-19	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459414	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459414&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969693	441290676					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948989	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1nn(-c2ccccc2)c(=O)[nH]1)C(O)=O	InChI=1S/C26H22ClFN4O5/c27-17-10-11-21(28)20(13-17)16-8-6-15(7-9-16)12-18(14-22(33)25(35)36)29-24(34)23-30-26(37)32(31-23)19-4-2-1-3-5-19/h1-11,13,18,22,33H,12,14H2,(H,29,34)(H,35,36)(H,30,31,37)/t18-,22-/m1/s1	HSBXOEULYNNMOV-XMSQKQJNSA-N	459415	US10759813, Example 19-20	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459415	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459415&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			136480953	441290677					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948990	O[C@H](C[C@@H](Cc1ccc(cc1Cl)-c1ccccc1Cl)NC(=O)c1ccc2nnn(OCOC=O)c2c1)C(O)=O	InChI=1S/C26H22Cl2N4O7/c27-20-4-2-1-3-19(20)15-5-6-16(21(28)10-15)9-18(12-24(34)26(36)37)29-25(35)17-7-8-22-23(11-17)32(31-30-22)39-14-38-13-33/h1-8,10-11,13,18,24,34H,9,12,14H2,(H,29,35)(H,36,37)/t18-,24-/m1/s1	OWIPYCVUBCHUHS-HOYKHHGWSA-N	459416	US10759813, Example 19-21	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459416	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459416&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903488	441290678					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948991	O[C@H](C[C@@H](Cc1ccc(cc1Cl)-c1ccccc1)NC(=O)c1c[nH]nn1)C(O)=O	InChI=1S/C20H19ClN4O4/c21-16-9-13(12-4-2-1-3-5-12)6-7-14(16)8-15(10-18(26)20(28)29)23-19(27)17-11-22-25-24-17/h1-7,9,11,15,18,26H,8,10H2,(H,23,27)(H,28,29)(H,22,24,25)/t15-,18-/m1/s1	HZMXACBBZVFIOM-CRAIPNDOSA-N	459417	US10759813, Example 20-1	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459417	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459417&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903489	441290679					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948992	O[C@H](C[C@@H](Cc1ccc(cc1Cl)-c1ccccc1)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C20H19ClN4O4/c21-16-9-13(12-4-2-1-3-5-12)6-7-14(16)8-15(10-18(26)20(28)29)23-19(27)17-11-22-25-24-17/h1-7,9,11,15,18,26H,8,10H2,(H,23,27)(H,28,29)(H,22,24,25)/t15-,18-/m1/s1	HZMXACBBZVFIOM-CRAIPNDOSA-N	459418	US10759813, Example 20-2	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459418	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459418&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903489	441290680					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948993	O[C@H](C[C@@H](Cc1ccc(cc1Cl)-c1ccccc1)NC(=O)c1nn(-c2cccc(Cl)c2)c(=O)[nH]1)C(O)=O	InChI=1S/C26H22Cl2N4O5/c27-18-7-4-8-20(13-18)32-26(37)30-23(31-32)24(34)29-19(14-22(33)25(35)36)11-17-10-9-16(12-21(17)28)15-5-2-1-3-6-15/h1-10,12-13,19,22,33H,11,14H2,(H,29,34)(H,35,36)(H,30,31,37)/t19-,22-/m1/s1	CYWFXSVERCTNMW-DENIHFKCSA-N	459419	US10759813, Example 20-3	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459419	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459419&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			136480956	441290681					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948994	O[C@H](C[C@@H](Cc1ccc(cc1Cl)-c1ccccc1)NC(=O)c1nn(-c2ccccc2)c(=O)[nH]1)C(O)=O	InChI=1S/C26H23ClN4O5/c27-21-14-17(16-7-3-1-4-8-16)11-12-18(21)13-19(15-22(32)25(34)35)28-24(33)23-29-26(36)31(30-23)20-9-5-2-6-10-20/h1-12,14,19,22,32H,13,15H2,(H,28,33)(H,34,35)(H,29,30,36)/t19-,22-/m1/s1	QDUJQXMNIMNXPG-DENIHFKCSA-N	459420	US10759813, Example 20-4	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459420	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459420&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			136480941	441290682					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948995	CN(C)C(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1Cl)-c1ccccc1	InChI=1S/C24H25ClN4O5/c1-29(2)23(32)20-13-19(27-28-20)22(31)26-17(12-21(30)24(33)34)10-16-9-8-15(11-18(16)25)14-6-4-3-5-7-14/h3-9,11,13,17,21,30H,10,12H2,1-2H3,(H,26,31)(H,27,28)(H,33,34)/t17-,21-/m1/s1	IYHUDPORHBEIAF-DYESRHJHSA-N	459421	US10759813, Example 20-5	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459421	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459421&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903490	441290683					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948996	COCCN(C)C(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1Cl)-c1ccccc1	InChI=1S/C26H29ClN4O6/c1-31(10-11-37-2)25(34)22-15-21(29-30-22)24(33)28-19(14-23(32)26(35)36)12-18-9-8-17(13-20(18)27)16-6-4-3-5-7-16/h3-9,13,15,19,23,32H,10-12,14H2,1-2H3,(H,28,33)(H,29,30)(H,35,36)/t19-,23-/m1/s1	DCMZABMYKAEYJH-AUSIDOKSSA-N	459422	US10759813, Example 20-6	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459422	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459422&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903491	441290684					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948997	CC(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1Cl)-c1ccccc1	InChI=1S/C23H22ClN3O5/c1-13(28)19-12-20(27-26-19)22(30)25-17(11-21(29)23(31)32)9-16-8-7-15(10-18(16)24)14-5-3-2-4-6-14/h2-8,10,12,17,21,29H,9,11H2,1H3,(H,25,30)(H,26,27)(H,31,32)/t17-,21-/m1/s1	VFCARFNPBXJFTK-DYESRHJHSA-N	459423	US10759813, Example 20-7	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459423	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459423&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903492	441290685					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948998	O[C@H](C[C@@H](Cc1ccc(cc1Cl)-c1ccccc1)NC(=O)c1cc(n[nH]1)-c1cccnc1)C(O)=O	InChI=1S/C26H23ClN4O4/c27-21-12-17(16-5-2-1-3-6-16)8-9-18(21)11-20(13-24(32)26(34)35)29-25(33)23-14-22(30-31-23)19-7-4-10-28-15-19/h1-10,12,14-15,20,24,32H,11,13H2,(H,29,33)(H,30,31)(H,34,35)/t20-,24-/m1/s1	WOQRSMGZUQKEQR-HYBUGGRVSA-N	459424	US10759813, Example 20-8	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459424	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459424&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903493	441290686					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
948999	O[C@H](C[C@@H](Cc1ccc(cc1Cl)-c1ccccc1)NC(=O)c1cc(n[nH]1)-c1ccccn1)C(O)=O	InChI=1S/C26H23ClN4O4/c27-20-13-17(16-6-2-1-3-7-16)9-10-18(20)12-19(14-24(32)26(34)35)29-25(33)23-15-22(30-31-23)21-8-4-5-11-28-21/h1-11,13,15,19,24,32H,12,14H2,(H,29,33)(H,30,31)(H,34,35)/t19-,24-/m1/s1	NVVQXSBJDCHOMA-NTKDMRAZSA-N	459425	US10759813, Example 20-9	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459425	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459425&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903494	441290687					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
949000	O[C@H](C[C@@H](Cc1ccc(cc1Cl)-c1cccc(Cl)c1)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C20H18Cl2N4O4/c21-14-3-1-2-11(6-14)12-4-5-13(16(22)8-12)7-15(9-18(27)20(29)30)24-19(28)17-10-23-26-25-17/h1-6,8,10,15,18,27H,7,9H2,(H,24,28)(H,29,30)(H,23,25,26)/t15-,18-/m1/s1	XRSBZVDLRWHWET-CRAIPNDOSA-N	459426	US10759813, Example 21-1	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459426	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459426&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903495	441290688					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
949001	COCc1cc([nH]n1)C(=O)N[C@@H](C[C@@H](O)C(O)=O)Cc1ccc(cc1Cl)-c1cccc(Cl)c1	InChI=1S/C23H23Cl2N3O5/c1-33-12-18-10-20(28-27-18)22(30)26-17(11-21(29)23(31)32)8-15-6-5-14(9-19(15)25)13-3-2-4-16(24)7-13/h2-7,9-10,17,21,29H,8,11-12H2,1H3,(H,26,30)(H,27,28)(H,31,32)/t17-,21-/m1/s1	WFNXAKDCVWMDFQ-DYESRHJHSA-N	459427	US10759813, Example 21-2	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459427	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459427&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903496	441290689					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
949002	O[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1ccc2nnn(O)c2c1)C(O)=O	InChI=1S/C24H20ClFN4O5/c25-16-6-7-19(26)18(11-16)14-3-1-13(2-4-14)9-17(12-22(31)24(33)34)27-23(32)15-5-8-20-21(10-15)30(35)29-28-20/h1-8,10-11,17,22,31,35H,9,12H2,(H,27,32)(H,33,34)/t17-,22-/m1/s1	VRIFOZXBORJFQY-VGOFRKELSA-N	459428	(2R,4R)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-hydroxy-4-[(3-hydroxy-3H-benzotriazole-5-carbonyl)-amino]-pentanoic Acid::US10759813, Example 22	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459428	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459428&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			57378092	441290690					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
949003	Cc1cccc(c1)-c1ccc(C[C@@H](C[C@H](O)C(O)=O)NC(=O)c2ccc3nnn(O)c3c2)cc1	InChI=1S/C25H24N4O5/c1-15-3-2-4-18(11-15)17-7-5-16(6-8-17)12-20(14-23(30)25(32)33)26-24(31)19-9-10-21-22(13-19)29(34)28-27-21/h2-11,13,20,23,30,34H,12,14H2,1H3,(H,26,31)(H,32,33)/t20-,23-/m0/s1	XVPHCZPBXCEVIA-REWPJTCUSA-N	459429	US10759813, Example 23-1	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459429	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459429&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969853	441290691					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
949004	Cc1ccc(Cl)cc1-c1ccc(C[C@@H](C[C@H](O)C(O)=O)NC(=O)c2ccc3NNN(O)c3c2)cc1	InChI=1S/C25H25ClN4O5/c1-14-2-8-18(26)12-20(14)16-5-3-15(4-6-16)10-19(13-23(31)25(33)34)27-24(32)17-7-9-21-22(11-17)30(35)29-28-21/h2-9,11-12,19,23,28-29,31,35H,10,13H2,1H3,(H,27,32)(H,33,34)/t19-,23-/m0/s1	PPSCWCNDAMGBFA-CVDCTZTESA-N	459430	US10759813, Example 23-2	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459430	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459430&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969773	441290692					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
949005	COc1ccccc1-c1ccc(C[C@@H](C[C@H](O)C(O)=O)NC(=O)c2ccc3nnn(O)c3c2)cc1	InChI=1S/C25H24N4O6/c1-35-23-5-3-2-4-19(23)16-8-6-15(7-9-16)12-18(14-22(30)25(32)33)26-24(31)17-10-11-20-21(13-17)29(34)28-27-20/h2-11,13,18,22,30,34H,12,14H2,1H3,(H,26,31)(H,32,33)/t18-,22-/m0/s1	WLGKDKROQNEOCI-AVRDEDQJSA-N	459431	US10759813, Example 23-3	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459431	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459431&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969891	441290693					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
949006	O[C@@H](C[C@H](Cc1ccc(cc1)-c1cc(Cl)ccc1Cl)NC(=O)c1ccc2nnn(O)c2c1)C(O)=O	InChI=1S/C24H20Cl2N4O5/c25-16-6-7-19(26)18(11-16)14-3-1-13(2-4-14)9-17(12-22(31)24(33)34)27-23(32)15-5-8-20-21(10-15)30(35)29-28-20/h1-8,10-11,17,22,31,35H,9,12H2,(H,27,32)(H,33,34)/t17-,22-/m0/s1	RREJQXHJEODYNE-JTSKRJEESA-N	459432	US10759813, Example 23-4	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459432	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459432&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969501	441290694					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
949007	O[C@@H](C[C@H](Cc1ccc(cc1)-c1cc(O)cc(Cl)c1)NC(=O)c1ccc2nnn(O)c2c1)C(O)=O	InChI=1S/C24H21ClN4O6/c25-17-8-16(9-19(30)11-17)14-3-1-13(2-4-14)7-18(12-22(31)24(33)34)26-23(32)15-5-6-20-21(10-15)29(35)28-27-20/h1-6,8-11,18,22,30-31,35H,7,12H2,(H,26,32)(H,33,34)/t18-,22-/m0/s1	YEFVNUUVSYNFQC-AVRDEDQJSA-N	459433	US10759813, Example 23-8	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459433	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459433&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67969628	441290695					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
949008	CC(C)([C@H](C[C@@H](O)C(O)=O)NC(=O)c1cc(n[nH]1)C(O)=O)c1ccc(cc1)-c1ccccc1			459434	5-[(S)-2-Biphenyl-4-yl-1-((R)-2-carboxy-2-hydroxy-ethyl)-2-methyl-propylcarbamoyl]-1H-pyrazole-3-carboxylic Acid::US10759813, Example 24	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459434	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459434&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			57378095	441290696					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
949009	CC(C)([C@H](C[C@@H](O)C(O)=O)NC(=O)c1c[nH]nn1)c1ccc(cc1)-c1ccccc1	InChI=1S/C22H24N4O4/c1-22(2,16-10-8-15(9-11-16)14-6-4-3-5-7-14)19(12-18(27)21(29)30)24-20(28)17-13-23-26-25-17/h3-11,13,18-19,27H,12H2,1-2H3,(H,24,28)(H,29,30)(H,23,25,26)/t18-,19+/m1/s1	RPBAJBSQRZHZMZ-MOPGFXCFSA-N	459435	US10759813, Example 25-1	Neprilysin	Human	 35.5								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459435	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459435&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			155903497	441290697					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
949010	CC(C)([C@H](C[C@@H](O)C(O)=O)NC(=O)c1cn(O)nn1)c1ccc(cc1)-c1ccccc1	InChI=1S/C22H24N4O5/c1-22(2,16-10-8-15(9-11-16)14-6-4-3-5-7-14)19(12-18(27)21(29)30)23-20(28)17-13-26(31)25-24-17/h3-11,13,18-19,27,31H,12H2,1-2H3,(H,23,28)(H,29,30)/t18-,19+/m1/s1	DPALQIWDPUMDTB-MOPGFXCFSA-N	459436	US10759813, Example 25-2	Neprilysin	Human	 3.55								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459436	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459436&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			89961837	441290698					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
949011	CC(C)([C@H](C[C@@H](O)C(O)=O)NC(=O)c1cc(O)no1)c1ccc(cc1)-c1ccccc1	InChI=1S/C23H24N2O6/c1-23(2,16-10-8-15(9-11-16)14-6-4-3-5-7-14)19(12-17(26)22(29)30)24-21(28)18-13-20(27)25-31-18/h3-11,13,17,19,26H,12H2,1-2H3,(H,24,28)(H,25,27)(H,29,30)/t17-,19+/m1/s1	FBFDJXQMWQXVPF-MJGOQNOKSA-N	459437	US10759813, Example 25-3	Neprilysin	Human	<1.000								US Patent		10.7270/Q2XW4NW0		aid1804768	US10759813	Gendron, R; Hughes, AD	9/1/2020	4/19/2021	Theravance Biopharma R&D IP, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=459437	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=459437&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			67970054	441290699					C02929		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	1DMT,1R1H,1R1I,1R1J,1Y8J,2QPJ,2YB9,5JMY,6GID,6SUK,6SVY,6THP,6XVP	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4